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Abstract 
To  survive  and establish  infections  in  host  tissues, pathogens  must  compete  with 
the  host organism  for  iron. One strategy for iron acquisition is to excrete  iron-
chelators,  called   siderophores,   with   very  high  affinity  to  ferric  iron.  Studies  have  
shown siderophores to be associated with growth  and virulence  of  some  pathogens. 
Inhibition of siderophore production is therefore considered an attractive target for the 
development of novel antimicrobial agents.  This dissertation describes biochemical 
investigations of two enzymes involved in siderophore production in Pseudomonas 
aeruginosa, an opportunistic pathogen. 
PchB catalyzes two pericyclic reactions in a single active site: 1.) an isochorismate-
pyruvate lyase reaction (breakdown of isochorismate to salicylate and pyruvate) and 2.) 
a chorismate mutase reaction (rearrangement of chorismate to prephanate). There is an 
ongoing debate in the field over the relative contributions of Near Attack Conformations 
(NAC) and Transition State Stabilization (TSS) to the molecular mechanism of pericyclic 
reactions. Steady-state kinetics of a K42H-PchB mutant with a pH-dependent charge on 
position 42 on the active site loop, previously shown to be important for catalysis 
reveals that lyase and mutase activities require the positive charge at that position for 
efficient catalysis. Covalent and non-covalent chemical-rescue experiments on mutants 
deficient of the positive charge at position 42 suggest that the positive charge at the 42 
position must be organized within the active site for efficient catalysis. Finally, quantum 
mechanical/molecular mechanical experiments on wild type and K42H PchB models 
look at the mechanism of catalysis of the lyase activity in more detail.  
PvdA is an accessory enzyme to the siderophore pyoverdin biosynthetic pathway of 
Pseudomonas aeruginosa. PvdA is an N-hydroxylating ornithine hydroxylase: it 
catalyzes the FAD dependent addition of oxygen to the N5-amine of the ornithine using 
NADPH as electron donor and molecular oxygen. Here we present two structures of 
PvdA with FAD in oxidized (1.9 Å resolution) and reduced (3.03 Å resolution) flavin 
forms. These are the first two structures of an N-hydroxylating Class B flavoprotein 
monooxygenase and the first structures of a Class B flavoprotein monooxygenase to 
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contain redox center, electron donor and product/substrate in the active site bound 
simultaneously 
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Chapter 1: Introduction 
1.1 Pseudomonas aeruginosa 
Pseudomonas aeruginosa is an aerobic rod shaped bacterium belonging to the bacterial 
family of Pseudomonadaceae, which includes all twelve members of the genus 
Pseudomonas. Like other Pseudomonads, Pseudomonas aeruginosa is a free-living 
bacterium, omnipresent in soil and water environments, and occasionally on the 
surfaces of plants and animals [1].  
Pseudomonas aeruginosa is a pathogen of clinical importance. According to the 
Centers for Disease Control, the overall incidence of P. aeruginosa infections in U.S. 
hospitals is about 4 per 1000 discharges [2].  P. aeruginosa is the fourth most 
commonly-isolated nosocomial (hospital-acquired) pathogen and accounts for 10.1 
percent of all nosocomial infections [2, 3]. Pseudomonas aeruginosa is an opportunistic 
pathogen; it is very successful at initiating infection in immunocompromised human 
hosts such as burn victims, AIDS patients, cystic fibrosis patients, or cancer patients 
undergoing chemo or radiotherapy [4-7]. Pseudomonas aeruginosa rarely infects 
uncompromised tissues. However, once tissue defenses are somehow compromised, 
there is hardly any tissue that it cannot infect. Pseudomonas infections range from 
simple joint, bone, ear, eye or gastro-intestinal infections [8] to more severe cardio-
respiratory infections and meningitis [9]. 
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1.1.1 Characteristics  
Pseudomonas aeruginosa is a diderm (Gram-stain negative) rod, with a single polar 
flagellum [10-12]. It is ubiquitous in a wide variety of soil and water environments. 
Pseudomonas is a facultative anaerobe: it is able to grow in the absence of O2 if NO3 is 
available as an electron acceptor [13].  Typically, Pseudomonas is able to grow as a 
biofilm, attached to some surface, or as a unicellular organism swimming by means of 
its flagellum [14, 15].  
Pseudomonas aeruginosa has very simple nutritional requirements[15]. It has the ability 
to grow in vitro using acetate as a source of carbon and ammonium sulfate as a source 
of nitrogen[12]. Like most pseudomonads, P. aeruginosa has evolved a wide metabolic 
versatility; organic growth factors are not required, and it can use a wide variety of 
hydrocarbons for growth [16-18]. Although optimal growth temperature is 37° C, it is 
able to grow at temperatures as high as 42° C and is resistant to high concentrations of 
salts, dyes and weak antiseptics [19]. Unfortunately, Pseudomonas aeruginosa strains 
have been found to be resistant to one or more commercially available antibiotics [20-
23].  
1.2 Current antimicrobials/antibiotics 
Current antibiotics can be classified into four major categories, according to their target 
(Table 1-1): cell wall synthesis, protein synthesis, membrane function and nucleic acid 
synthesis [24]. 
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Table 1-1: Current Available Antibiotics1 
Class Representative Compounds Mode of Action 
   
1. Cell Wall 
Synthesis 
Inhibitors 
Β-lactams 
(e.g. penicillins) 
Irreversibly bind to transpeptidase. 
  
Vancomycin Inihibit peptidoglycan synthesis by binding to 
NAM/NAG peptides 
  
bacitracin Interferes with dephosphorylation of C55-isoprenyl 
pyrophosphate. 
     
     
2. Protein 
Synthesis 
             Inhibitors 
Rifamycins (e.g. 
rifampicin) 
Inhibit mRNA synthesis by binding to β subunit of 
RNA polymerase 
   
 Linezolid Blocks translation initiation complex binding to the 
50S subunit of the ribosome 
   
 Tetracyclines Bind A site on ribosome, preventing aminoacyl-tRNA 
entry. 
   
 Aminoglycosides Bind to the 30S subunit of the ribosome, blocking 
translocation and proofreading process 
   
 Chloramphenicols Bind 50S subunit of the ribosome and prevent peptidyl 
transfer step during elongation 
   
 Macrolides Bind to P site on 50S subunit of the ribosome, 
blocking elongation 
   
 Fusidic acids Block turnover of EF-G 
   
 Puromycins Bind to ribosome A site, participate in peptidyl 
formation, inducing early termination. 
     
     
3. Cell 
Membrane 
Disruptors 
Polymixins Binds LPS on diderm bacteria, disrupts cell 
membrane phospholipid organization (like a 
detergent) 
     
     
4. Nucleic 
Acid 
Synthesis 
Inhibitors 
Quinolones Binds and interferes with DNA gyrase and 
topoisomerases 
   
 Sulphonamides Inhibit synthesis of folate nucleic acid precursors. 
 Trimethoprim 
 Metronizadole 
   
Table adapted from Walsh, 2003 [25] 
4 
 
1.2.1 Cell wall synthesis inhibitors.  
Cell wall synthesis inhibitors can be classified into two groups: beta-lactam antibiotics 
and cell wall synthesis inhibitors (Table 1-1, 1). This class of antibiotics includes 
penicillins, cephalosporins, monobactams and carbapenems. Beta lactam antibiotics act 
by irreversibly binding to the catalytic serine residue in the active site of transpeptidase 
blocking the final transpeptidation step in the synthesis of the peptidoglycan layer in 
bacterial cell walls[26]. Bacteria have evolved several mechanisms of resistance against 
beta-lactam antibiotics, including production of beta-lactamases, decreased cell wall 
permeability, and mutations to transpeptidases [27]. Cell wall synthesis inhibitors, such 
as vancomycin and bacitracin, inhibit production of phospholipids and peptidoglycan, 
either via binding to the D-alanyl-D-ala moieties of the NAM/NAG peptides in Gram-
positive bacteria (vancomycin) [28], or by interfering with the dephosphorylation of 
the C55-isoprenyl pyrophosphate thus blocking transport of peptidoglycan building 
blocks to the periplasm (bacitracin) [29]. 
1.2.2 Protein synthesis inhibitors 
This class of antibiotics includes a wide variety of compounds that target most stages of 
protein synthesis in prokaryotes (Table 1-1, 2). Rifamycins (rifampicin) act on mRNA 
synthesis; they inhibit the DNA-dependent RNA polymerase by binding its beta subunit, 
preventing transcription [30, 31]. Linezolid, an oxazolidinone, blocks the formation of the 
translation initiation complex by binding to the 50S subunit of the ribosome [32, 33]. 
Tetracyclines block the A site of the ribosome, also preventing translation, in this case 
by preventing aminoacyl-tRNA entry [34]. Aminoglycosides bind to the 30S subunit of 
the ribosome, and have several mechanisms of action, including inhibition of ribosomal 
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translocation and have also been suggested to disrupt the integrity of the cell 
membrane [35]. Chloramphenicols block elongation by binding to the 30S subunit of the 
ribosome and preventing the peptidyl transfer step during elongation[36, 37]. 
Marcrolides and fusidic acid inhibit ribosomal translocation. Macrolides do so by binding 
to the P site on the 50S subunit of the ribosome. Fusidic acids also block ribosomal 
translocation by blocking turnover of elongation factor G from the ribosome [38-40]. 
Puromycins bind to the ribosome’s A site, and participates in peptide formation, 
producing a peptidyl-puromicin that induces early termination [41-43].  
1.2.3 Cell membrane disruptors.  
The integrity of outer and cytoplasmic membranes is vital to survival of bacteria. 
Compounds that can disrupt and disorganize the cell membranes rapidly kill the cells. 
Unfortunately, due to the similarities in phospholipid composition of bacterial and 
eukaryotic membranes, cell membrane disruptors are rarely specific enough to be used 
systemically. This class of antibiotics functions by disrupting the structure of the cell 
membrane or by inhibits its function (Table 1-1, 3). Polymyxin, a cell membrane 
disruptor, is effective mainly against diderms, binding to lipopolysaccharides on the cell 
surface and disrupting cell membrane phospholipids like a detergent[44].  
1.2.4 Nucleic acid synthesis antibiotics 
Nucleic Acid Synthesis inhibitors comprise a wide variety of molecules that interfere with 
DNA replication. They include quinolones, trimethoprim and metronizadole (Table 1-1, 
4). Quinolones are a group of antibiotics that block DNA synthetic apparatus in bacteria 
by interfering with DNA gyrase and topoisomerases [45, 46]. Most other antibiotics that 
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interfere with nucleic acid synthesis, like sulphonamides, trimethoprim, and 
metronizadole, block or inhibit precursor metabolites to nucleic acid biosynthesis, such 
as folates[25, 47].  
Unfortunately, pathogenic bacteria such as Pseudomonas aeruginosa have evolved 
resistance to antibiotics from one or more of these categories and there is an increased 
prevalence of multidrug resistant strains (MDR), extensive drug-resistant strains (XDR) 
and in some cases pandrug-resistant strains (PDR)[48, 49]. Mechanisms of resistance 
can include hypermutability, efflux pump over-expression, over-expression of metallo-
betalactamases, and point mutations in topoisomerases[49, 50].  Multi-drug resistance 
results in many first-line antimicrobials/antibacterials being completely ineffective in 
combating Pseudomonas infections. In such cases, antimicrobial cocktails and less 
conventional drugs with higher human toxicity might need to be used. It is therefore 
imperative to find new antimicrobial targets. One such possible target is nutrient (in 
particular iron) acquisition.  
1.3 Iron usage in bacteria  
Most known living organisms, including pathogenic bacteria, require iron for survival. 
However, because of its toxicity at high concentrations in its ferrous form (Fe2+) and low 
solubility in its ferric form (Fe3+), iron bioavailability is very low in host tissues[51-53]. 
The concentration of unbound iron in humans can be as low as 10-18 – 10-24 molar in an 
average individual [54]. Due to hypoferremia during an infection, where ferritin and 
lactoferrin production is increased, soluble iron concentrations can dip even lower[55, 
56].  Most iron in mammals is bound in heme containing proteins (e.g. hemoglobin, 
myoglobin) and iron transport proteins (e.g. lactoferrin, transferrin, ferritin). Because of 
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such low iron availability in host environments, pathogenic bacteria have evolved 
multiple methods of iron uptake, the most prevalent being the production and secretion 
of siderophores [56-60].  
1.3.1 Transferrin binding  
Some pathogenic bacteria, notably members of the Neisseraceae and Pasteurellaceae 
genera, are able to acquire iron directly from the host by producing soluble transferrin 
binding proteins targeting host transferrins (Figure 1-1, A). Transferrin binding proteins 
are able to extract the iron from the transferrin. The iron is transported across the outer 
membrane and subsequently periplasmic-protein-dependent transport systems transfer 
the iron from the periplasm into the cytoplasm [58].   
1.3.2 Heme binding  
Other pathogenic bacteria, including most diderms and Pseudmonas aeruginosa, are 
able to obtain required iron from hemes. These organisms are able to acquire hemes 
from the environment, either via heme binding directly to outer membrane receptors, or 
through the secretion of hemophores, heme carrier proteins, that are able to sequester 
heme from their host counterparts, and internalize it through TonB-dependent outer 
membrane receptors (Figure 1-1, B) [61-64].  
1.3.3 Environment modification 
Some facultative anaerobes, such as some Listeria species, are able to obtain iron by 
generating an acidic and anaerobic microenvironment around themselves that results in  
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Figure 1-1: Iron uptake pathways in diderm bacteria. (A) Transferrin receptors 
recognize iron-bound transferrin, sequester and internalize the iron. (B) Heme intake 
occurs either through secreted hemophores or receptors recognizing free hemes. (C) 
Siderophore mediated iron uptake. Siderophores are synthesized in the cytoplasm, 
matured in the periplasm and secreted via specialized secretory channels. Iron-bound 
siderophores are recognized and internalized via siderophore receptors in the outer 
membrane. ABC transporters transport the iron-siderophore and the iron can be utilized.  
A 
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the reduction of Fe3+ to Fe2+ in transferrins and lactoferrins, inducing iron release. The 
now soluble Fe2+ is actively transported into the cell [65, 66].  
1.3.4 Siderophore mediated iron acquisition 
Siderophore mediated iron acquisition is similar to the hemophore system in that it is 
based on a shuttle mechanism. However, the siderophore mediated iron acquisition 
system makes use of small compounds called siderophores with a high affinity for ferric 
iron (with Ka of 1020 – 1050 M) [67-70] (Figure 1-1 C). In contrast to the hemophore 
system, siderophores are able to sequester ferric iron from a wide variety of host 
sources, including transferrins and lactoferrins (but interestingly, not hemes)[71]. 
Siderophore-dependent iron acquisition pathways can be found both in bacteria and 
yeast, and some plants are able to utilize siderophores secreted by other organism for 
their own iron acquisition[67, 71]. However, mammals do not have siderophore 
mediated iron acquisition pathways. Siderophore production mostly occurs during 
periods of iron starvation, when the intracellular iron concentration drops below the 
10−6 M critical for microbial growth [72]. Secreted siderophores complex with Fe3+ and 
either the iron-bound siderophore is taken up by specific transporters, or siderophore-
bound Fe3+ is reduced to Fe2+  by extracellular or membrane ferric-chelate reductases. 
Some bacteria (as well as some yeast and plants) possess the ability to uptake and use 
xenosiderophores: they possess ferric-chelate reductases or uptake systems for 
siderophores not synthesized by themselves [57, 62, 65, 73]. Iron that is not released 
outside of the cell or in the periplasm, is released by intracellular ferric-siderophore 
reductases or by ferric-siderophore hydrolases that disassemble the siderophore-iron 
complex[74]. However these mechanisms are not very well understood. It is uncertain 
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whether the iron can be used immediately by the bacterium once the siderophore-iron 
complex is disassembled, or if an intermediate storage step is required prior to usage 
[75].  
1.3.4.1 Classes of siderophores 
Siderophores are highly varied in structure. There are over 500 known siderophores 
that can be divided into three main classes depending on the nature of the moieties 
donating the oxygen ligands for Fe(III) coordination: 1.) catecholates and phenolates 
that contain an aryl cap with carbonyl oxygens, 2.) hydroxamates that contain a 
hydroxamic acid cap, 3.) and (α-hydroxy-)carboxylates. A fourth “mixed-type” 
siderophore class groups all those siderophores with more than one type of iron binding 
moiety (Figure 1-2) [76]. 
1.3.4.2 Siderophore chemistry 
Siderophores form tight and stable complexes with ferric iron. Fe3+ is a hard Lewis acid, 
and is thus strongly solvated in aqueous solution (forming an octahedral 
Fe(H2O)63+ complex). The siderophore donor oxygen groups replace the water molecule 
interactions, surrounding the Fe3+ in a hexacoordinated state with an octahedral 
geometry mimicking the geometry of the aqueous ion. A 1:1 complex or a 1:2 complex 
with Fe3+ is generally formed, depending on the number of coordinating oxygens in the 
siderophore iron binding pocket. Vacancies may be occupied by alternative oxygen 
donors such as water molecules. Or even the formation of mixed complexes[67-70]. 
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Figure 1-2: Types of siderophores: Siderophores can be classified into 4 categories: 
Catecholate/phenolate siderophores (siderophores with salicylate or catechol moieties), 
Hydroxamate siderophores (siderophores with hydroxamic acid iron binding moieties), 
hydroxycarboxylate siderophores (with (α-hydroxy-)carboxylates as iron binding 
moieties), and finally mixed siderophores containing more than one type of iron binding 
moiety in the structure. 
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1.3.4.3 Siderophore regulation 
 In bacteria, iron homeostasis, including siderophore gene regulation, is mediated by 
ferric uptake repressor Fur and various activators, including alternative sigma factors,  
two-component sensory transduction systems, and AraC-type regulators, which sense 
extra or intracellular Fe-siderophores [15]. 
1.3.4.4 Siderophore biosynthesis 
Siderophores are generally comprised of a peptide backbone with a prevalence of non-
proteogenic amino acids, with iron chelating moieties generated by accessory proteins 
forming the oxygen rich iron-binding core of the siderophore [72]. Although I will give a 
brief overview of siderophore biosynthesis and non-ribosomal peptide synthetases in 
the following paragraphs, more detailed comprehensive reviews of siderophore 
biosynthesis can be found in references [67, 71, 76, 77]. The peptide backbones of 
siderophores are nonribosomal peptides; nonribosomal peptide synthetases (NRPS) 
are responsible for the synthesis of these peptide backbones instead of ribosomes [76]. 
These enzymes enable peptide bond formation between amino acids that cannot be 
incorporated through ribosomal synthesis. NRPS’s, originally identified as catalyzing the 
synthesis of antibiotics, are multi-modular enzymes that produce peptide products of a 
particular sequence without the need for an RNA template [78, 79]. Instead, the order of 
NRPS domains dictates the order of the amino acids in the peptide, essentially like an 
assembly line [78, 80]. The elongating chains are tethered via thiol groups, incorporated 
as phosphopantetheinyl arms bound to the NRPS via peptidyl carrier protein domains 
(PCPs).  The NRPS assembly line runs via a multiple-thiol templating process, with the 
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phosphopantetheinyl-tethered peptide translocating down to the next carrier protein 
domain[78, 81].  
The NRPS assembly complex is composed of autonomous domains, each of which 
carries out steps of monomer selection and activation, chain elongation, and chain 
termination. Each NRPS complex needs to carry out four kinds of catalytic operations. 
Typically, an elongation module of an NRPS assembly line has the three domains; 
peptidyl carrier protein (PCP), adenylation domain, and a catalytic condensation 
domain[78, 80]. First, the enzyme phosphopantetheinyl transferase (PPTase) catalyzes 
the post-translational modification of a serine through the addition of a 
phosphopantathenate (P-pant) moiety to a PCP domain side chain. Once the PCP 
domain is activated, an adenylation domain selects and activates the amino acids or 
other metabolites to be incorporated into the siderophore chain. The adenylation 
domains behave similarly to aminoacyl tRNA synthetases: the amino acid selected by 
the adenylation domain active site is converted to an activated aminoacyl-AMP using 
ATP as cosubstrate. The activated aminoacyl-AMP monomer is then tethered to the 
thio-pant-PCP domain to form an activated aminoacyl thioester (aminoacyl-S-PCP). The 
elongation step is carried out by the condensation domains of the NRPS.  The peptide 
bond-forming step involves the peptidyl-S-PCP as the donor cosubstrate and the 
proximal downstream aminoacyl-S-PCP as the attacking acceptor substrate. The 
translocated chain grows by one peptide bond but is still tethered as a 
thermodynamically activated acyl-S-PCP, and is ready for another elongation cycle by 
the condensation domain of the next downstream module. Chain termination and 
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release of the full-length peptide requires chemical cleavage from the enzyme assembly 
line via a thioesterase found in the C-terminus of the NRPS[78-81]. 
 
1.4 Siderophores of Pseudomonas aeruginosa 
 
Pseudomonas aeruginosa produces two siderophores, pyochelin and pyoverdin, 
produced via two distinct biosynthetic pathways.  
 
1.4.1 Biosynthesis of pyochelin 
Two biosynthetic operons, pchDCBA and pchEF, have been identified, clustered 
together in the chromosome with the pyochelin receptor gene fptA [82]. The products of 
these genes produce not only pyochelin, and precursor building blocks, 
dihidroaerugionate and salicylate. Both operons are repressed by the Fur protein in the 
presence of iron, and autoregulated by a positive-feedback loop requiring transcriptional 
regulator PchR. The pchR gene is located between the two biosynthetic operons[83].  
In the initial steps of pyochelin biosynthesis, salicylate is made from chorismate (derived 
from the shiikimate pathway) via isochorismate (Figure 1-3, A) [83]. Production of 
salicylate from chorismate is catalyzed by two accessory enzymes. PchA, an 
isochorismate synthase, catalyzes the chorismate to isochorismate reaction. 
Isochorismate-pyruvate lyase PchB subsequently breaks down the isochorismate to 
produce salicylate and pyruvate[83-85]. L-cysteine the other precursor building block, is 
adenylated by the adenylation domain of PchE (an NRPS), and tethered to PchE via a  
15 
 
D 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-3: Pyochelin Biosynthesis in P. aeruginosa: (A) Enzymes PchA and PchB 
generate salicylate from chorismate, which is subsequently adenylated by PchD. (B) 
PchE, an NRPS, loaded with activated cysteine, catalyzes the condensation of the 
salicylate-adenylate with the cysteine, and the cyclization of the cysteine (C) to form 
hydroxyphenyl-thiazoline. (D and E) A second NRPS, PvdF, incorporates and cyclizes a 
second cysteine to the hydroxyphenyl-thiazoline to form pyochelin precursor 
hydroxyphenyl-4,2-bis-thiazoline, which upon release from PchF is reduced and 
methylated by maturation enzymes including PchG[83]. Red box identifies the focus 
chapters 2-5 of this dissertation. PchC (not shown) is a thioesterase hypothesized to 
play a role in proofreading and NRPS recycle [83]  
A 
B 
C 
E 
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PPT prosthetic group (Figure 1-3, B). Salicylate is also adenylated by PchD and 
subsequently tethered to PchE (Figure 1-3, C) [83].  Subsequent cysteine cyclization 
and condensation reactions form a hydroxyphenyl-thiazoline intermediate, released by 
thioesterase PchC to form hydroxyphenyl-thiazolinyl-carboxylate. PchF, another NRPS, 
adenylates a second molecule of L-cysteine and catalyzes the condensation of the 
hydroxyphenyl-thiazolinyl-carboxylate intermediate with cysteinyl-S-PchF and generates 
the second thiazoline ring (Figure 1-3, D) [83]. The hydroxyphenyl-4,2-bis-thiazoline 
backbone undergoes reduction and methylation before biosynthesis is terminated and 
pyochelin is released from PchF via cleavage of the remaining thioester bond (Figure 1-
3, E) releasing pyochelin (Figure 1-4) [83]. 
1.4.2 Biosynthesis of Pyoverdin 
 Pyoverdin synthesis has been studied in most detail in the P. aeruginosa strain PAO1 
[86]. Synthesis of pyoverdin requires four NRPSs: PvdL, PvdI, PvdJ and PvdD[86]. 
Based on the order of amino acids in pyoverdin,  the transfer of intermediates occurs 
sequentially from PvdL through PvdI and PvdJ to PvdD. Pyoverdin synthesis starts with 
PvdL, which incorporates L-Glu, D-Tyr and L-Dab (generated by accessory enzyme 
PvdH, Figure 1-5, A) into a precursor peptide. L-Dab and D-Tyr are condensed to a 
tetrahydropyrimidine ring and then modified to form the dihydroxyquinoline 
chromophore. PvdI and PvdJ elongate the peptide backbone, via the sequential addition 
of D-Ser, L-Arg, D-Ser, and N5-formy, N5-hydroxyornithine (fOHOrn) by PvdI, and L-Lys 
and fOHOrn by PvdJ (Figure1-5, C) [86, 87]. N5-formyl,N5-hydroxyornithine is generated 
through the hydroxylation of ornithine to N5-hydroxyornithine by FAD-dependent 
ornithine hydroxylase (PvdA) and formylation by  
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Figure 1-4: Structure of Pyochelin from Pseudomonas aeruginosa strain  PAO1. 
Pyochelin is composed of two cyclized cysteines and a salicylate moiety (in bold). It has 
two iron binding moieties (in red), and therefore hexacoordinated Fe3+ has to coordinate 
with two pyochelin molecules in order to form a stable complex.  
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hydroxyornithine transformylase PvdF (Figure 1-5 B)[86, 87]. L-Serine is epimerized to 
D-Serine via the epimerase domain found in PvdI prior to incorporation onto the 
backbone.  Finally, PvdD adds two threonines to the backbone, completing the 
immature peptide (Figure 1-5, C and D).  Although synthesis of the immature peptide 
occurs in the cytoplasm, there is evidence to suggest that the immature peptide is 
transported to the periplasm with the help of PvdE and PvdM, via ABC transporters, and 
it is in the periplasm, with the help of accessory enzymes PvdG, PvdO, PvdP, PvdQ and 
PvdN, that the mature Pyoverdin is formed (Figure 1-6) [86, 87].   
1.5 Siderophore Biosynthesis: Implications for Drug Discovery  
Targeting siderophore biosynthesis for antimicrobial drug discovery offers multiple 
advantages. First and foremost, siderophore biosynthetic pathways are very specific to 
bacteria and fungi, but not mammals. Inhibitors developed to target siderophore 
biosynthetic pathways have a lower chance of inhibiting human pathways as secondary 
targets. Although over 500 siderophores have been identified, these can be classified 
into 4 discrete groups each of which share common biosynthetic pathways. Inhibitors 
developed to target a specific biosynthetic pathway are likely to inhibit homologous 
pathways in other organisms. While reducing virulence and reducing growth rate, 
inhibition of siderophore biosynthesis does not kill the bacteria, reducing pressure on 
the bacterial population to evolve mechanisms against the inhibitors, preventing 
development of resistance. Likewise, these inhibitors would offer new targets for which 
the bacteria have yet to develop resistance.  
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Figure 1-5: Pyoverdin Biosynthesis: (A) L-Dab generated by PvdH, L-Glu and L-Tyr 
are condensed by NRPS PvdL to form the dyhydroxyquinolone chromophore 
intermediate. (B) PvdA hydroxylates ornithine, and PvdF transformylates the PvdA 
product to form N5-formyl-N5-hydroxyornithine (fOHOrn) with the iron binding 
hydroxamate moiety. (C) Precursors are assembled by NRPSs PvdI, PvdJ and PvdD to 
form the backbone of the Pyoverdin (Ferribactin). (D) Ferribactin is exported to the 
periplasm, where maturation enzymes reduce and methylate the ferribactin to form the 
mature pyoverdin. Yellow box indicates enzymes PvdA and PvdF, which are the focus 
of chapters 6-8 and Appendix. 
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Figure 1-6. Structure of Pyoverdin from Pseudomonas aeruginosa strain PAO1. 
The pyoverdin backbone is assembled from amino acid building blocks assembled 
together by non-ribosomal peptide synthetases: the chromophore is assembled from L-
Glu, D-Tyr and L-Dab. D-Ser, LArg, L-Lys, and L-Thr serve as the peptide backbone of 
the molecule, while the hydroxamates of L-fOHOrn serve as iron binding moieties.  
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Chapter 2: PchB Introduction 
2.1 General Enzymology  
For a reaction to happen, reactant molecules must have enough energy to be able to 
cross a potential energy barrier (activation energy). Depending on a variety of factors 
(temperature, pressure, recent collision history)[1, 2], different populations of molecules 
possess varying levels of energy. Some, but not all, of these populations, will have 
enough energy to cross the energy barrier for the reaction to occur. The lower the 
potential energy barrier to reaction, the more reactants have sufficient energy and, 
hence, the faster the reaction will occur. Small reductions in the potential energy barrier 
may result in significant increases in the rate of reaction. Enzymes behave as catalysts: 
they accelerate reactions by lowering potential energy barrier, as compared to the 
uncatalyzed reaction, without altering the chemical equilibrium between reactants and 
products. This increase in the rate of reaction (which can be as high as 1020 fold), allows 
reactions in biological systems to occur at a short enough timescale to support life [3].  
2.1.1 Transition State Theory 
Enzymes are able to increase rates of reactions by providing a reaction pathway with a 
transition state whose free energy of activation is lower than that of the uncatalyzed 
reaction, through binding of the substrate to the active site, and promoting and 
stabilizing the transition state (Figure 2-1) [4]. In order to do so, enzymes (E) bind 
their substrates (S) in the active site to form an enzyme-substrate complex (ES). 
Formation of the ES complex promotes the transition towards an activated, high energy 
state (transition state, TS‡)[5]. As bond breaking and bond forming events 
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Figure 2-1: Reaction Coordinate.   An example of a reaction coordinate diagram for 
the reaction 
+ 	 ↔ 	 ↔ ‡ ↔ ↔ +  
The starting substrate is on the left, the product on the right. The free energy of the 
molecule is given by the black line (uncatalyzed reaction) and red line (catalyzed 
reaction). The transition state is the species with the highest free energy. The higher the 
free energy of the transition state, the slower the rate of the reaction. Formation of the 
ES complex through the binding of the substrate to the enzyme’s active site promotes 
the formation of the transition state, lowering the free energy of activation.  
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 occur, substrate converts into product in the active site (EP), which is then released (E 
+ P). The enzyme-catalyzed reaction can thus be written as follows: 
+ 	 ↔ 	 ↔ ‡ ↔ ↔ +  
2.1.2 Transition State 
The transition state is the theoretical short lived, highest energy conformation of the 
molecule along the energy reaction coordinate [6]. It does not completely resemble 
substrate or product, as it is in a state in which bond breaking and bond forming events 
are simultaneously happening. Linus Pauling was the first to popularize Michael 
Polanyi’s idea that enzymes lower the activation energy barrier by preferentially binding 
and stabilizing the transition state of a reaction [4]. The enzyme initially binds to the 
reactant through hydrophobic, electrostatic, or van der Waals interactions to form the 
ES complex. Binding of the substrate to the enzyme and the formation of the ES 
complex promotes the formation of the transition state by preorganizing the substrate, 
reducing entropy by reducing the degrees of freedom of the molecule, and bringing 
reactive groups closer to each other. Binding also involves the loss of the protective 
solvation sphere around the substrate, as hydrogen bonds between water and substrate 
are replaced by interactions with specific residues in the active site [4, 7-9].  
2.1.3 Active Site 
The reactive center of the enzyme, its active site, is the substrate binding pocket where 
residues are precisely positioned to provide specificity for the substrate as well as to 
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promote catalysis by providing reactive groups or by promoting the right 
microenvironment. Nucleophiles or acid/base residues provide chemically reactive 
groups, whereas hydrogen bond donors and acceptors, charged residues, and 
hydrophobic pockets create a microenvironment suitable to stabilize the transition state 
and promote catalysis.  Shape and residue composition of the active site of the enzyme 
contribute to a set of mechanisms through which the enzyme is able to lower the energy 
of activation of the reaction.   These mechanisms include entropy loss in ES formation, 
destabilization of ES due to strain, desolvation, or electrostatic effects; covalent 
catalysis; general acid or base catalysis; metal ion catalysis; and proximity and 
orientation. Usually, enzyme catalysis requires contributions from one or more of these 
mechanisms[10-12]. 
2.1.4 Mechanisms of Catalysis 
2.1.4.1 Entropy loss and destabilization of ES complex 
Raising the energy of the ES complex, either through a loss of entropy due to substrate 
binding or destabilizing the substrate due to strain, distortion or desolvation will increase 
the enzyme-catalyzed reaction rate[12]. The enzymatic rate is determined by the 
difference in energy between ES and ES‡.  The smaller this difference, the faster the 
enzyme-catalyzed reaction [13]. The formation of the ES complex resulting from  the 
binding of the substrate to the active site results in a highly organized complex as 
compared to E + S in solution (highly disordered), resulting in a net loss of 
entropy. Destabilization of the ES complex through structural strain, desolvation, or 
electrostatic effects is a consequence of the enzyme binding the transition state more 
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strongly than the substrate: because the substrate does not have the same shape as 
the transition state,  when the substrate binds, the “induced fit” results in distortion or 
strain in the substrate, the enzyme, or both. Substrate binding in the active site results 
in desolvation of charged groups, which leads to higher reactivity of the substrate [12]. 
2.1.4.2 Covalent Catalysis 
Enzymes are also able to derive catalytic power through formation of covalent 
bonds between enzyme and substrate[14]. 
For a given uncatalyzed reaction: 
+ 	 → +  
where “A” is the compound undergoing the reaction, “Y” is a nucleophillic attacking 
group and X is the leaving group, the theoretical enzymatic version of this reaction 
involving formation of a covalent intermediate would be described as: 
		 + 	 → + +  
+ + → +  
where “E” is the enzyme, “AX” is one substrate of two chemical moieties (“A” and “X”), 
and “Y” is a second substrate. If the acceptor group on the enzyme is a better attacking 
group than Y and a better leaving group than X, the rate of the reaction will be 
increased [11, 14]. Typical nucleophilic centers for catalysis, such as amines, 
carboxylates, aryl and alkyl hydroxyls, imidazoles, and thiol groups, readily attack 
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electrophilic centers of substrates, forming covalently bonded enzyme-substrate 
intermediates (EA) [11, 13, 14]. Typical electrophilic centers in substrates would include 
phosphoryl groups, acyl groups, and glycosyl groups[13].  Covalent electrophilic 
catalysis usually involves coenzyme adducts that generate electrophilic centers[13].  
2.1.4.3 Acid/Base Catalysis 
There are two types of acid-base catalysis[13]. In specific acid-base catalysis, H+ and 
OH- ions accelerate the reaction[14]. In general acid-base catalysis, an acid or a base 
other than H+ or OH- accelerates the reaction. Side chains involved in acid-base 
catalysis are most commonly ionizable side chains with pKas near physiological pH 
values (e.g. histidine, which has an imidazole sidechain with a pKa of 6.1, is a good 
general acid or base) [14].  
2.1.4.4 Metal Ion Catalysis 
Metal-activated enzymes are enzymes that require a metal ion for catalysis. 
Metalloenzymes on the other hand are enzymes that require a metal ion for stability as 
well as for catalysis. Metal ions can be used by the enzyme as electrophilic catalysts, 
stabilizing an increased electron density or a developing negative charge during 
reactions. Metal ions also increase the acidity of a nucleophile, making it more reactive 
[11-13].  
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2.1.4.5 Proximity Effects 
By bringing reactants closer together in the active site, enzymes are able to raise the 
reactants’ “effective” concentration over that of the substrates in solution, resulting in an 
increased reaction rate. In addition to bringing reactants together, the enzyme also 
orients the reactive groups of the substrates, to encourage catalysis [11-13].  
2.2 PchB 
PchB is an accessory protein to the pyochelin biosynthetic pathway in P. aeruginosa. 
PchB is an isochorismate-pyruvate lyase, catalyzing the breakdown of isochorismate 
into salicylate and pyruvate[15].   
2.2.1 Reactions Catalyzed by PchB 
PchB catalyzes two pericyclic reactions (Figure 2-2). Physiologically, it catalyzes 
the breakdown of isochorismate into salycilate and pyruvate in a concerted but 
asynchronous pericyclic {1,5}-sigmatropic shift with a quantitative hydrogen transfer 
from  C2  to  C9  [16,  17]  (Figure 2-2, A). PchB can also catalyze a non-physiological 
chorismate mutase reaction, a pericyclic Claisen rearrangement of chorismate to 
prephenate with a concerted but asynchronous {3,3}-sigmatropic transfer of the 
pyruvate tail from the C3 ether linkage to a C1-C9 linkage [18] (Figure 2-2, B). 
However, the chorismate mutase activity shows a much  lower catalytic efficiency 
(isochorismate-pyruvate lyase kcat/Km of 4.11x104 M-1s-1 versus chorismate mutase 
kcat/Km of 1.96x102 M-1s-1 [19]).  
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Figure 2-2: Reactions catalyzed by PchB. PchB catalyzes two pericyclic 
reactions: (A) an isochorismate-pyruvate lyase reaction, breaking down isochorismate 
to generate salicylate and pyruvate. The salicylate goes on as a precursor building 
block for pyochelin. (B) PchB is also able to catalyze a non-physiological chorismate 
mutase reaction, albeit significantly less efficiently than the lyase activity, generating 
prephenate from chorismate. The mutase pericyclic reaction and its transition state 
have been widely studied and are considered a standard reference in the field. 
However, the lyase transition state is somewhat unusual, in that it includes a hydrogen 
as part of the ring structure of the transition state. The chorismate precursor for both of 
these reactions is generated through the Shikimate pathway, part of the aromatic amino 
acid biosynthetic pathway [15]. Pericyclic reactions are unusual in nature, but PchB is 
able to catalyze two pericyclic reactions in the same active site, offering a unique 
opportunity for mechanistic enzymology.  
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2.2.2 Pericyclic Reactions 
A pericyclic reaction is a type of reaction, usually a rearrangement, where the transition 
state of the molecule has a cyclic geometry, and the reaction progresses in a concerted 
(but not necessarily synchronous) fashion [20]. While pericyclic reactions are an 
important tool in organic synthetic chemistry [20], they are unusual in biological 
systems. Enzymatic pericyclic reactions do not require direct contribution from the 
enzyme [21, 22].  No protons or electrons are donated or accepted from enzyme or 
cofactors, and there are no covalent intermediates [21, 22]. Binding of the substrate to 
the active site leads to organization into a transition state, and product formation [22]. 
Since reactions do not require direct contribution from the enzyme, many traditional 
ideas (e.g. acid-base catalysis, covalent intermediates, metal ion catalysis) about 
enzyme catalysis do not apply.  
Although the chorismate mutase reaction has been studied in detail, the isochorismate-
pyruvate lyase reaction has a more unusual pericyclic transition state with a hydrogen 
atom forming part of the transition state cyclization event[23-25]. Traditional concepts 
regarding enzyme catalysis do not apply to pericyclic reactions, and there is an ongoing 
debate in the field regarding electrostatic stabilization of the transition state by the active 
site and the driving catalytic mechanism of the reaction. The ability of PchB to catalyze 
two pericyclic reactions in the same active site, makes this enzyme a very interesting 
candidate to study fundamental ideas of transition state theory. Moreover inhibitors for 
this class of enzymes have been found to be poor drug candidates due to low binding 
affinity[26]. Understanding the catalytic mechanism that underlies these reactions will 
help understand and improve drug design and development. 
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2.2.3 Structure of PchB 
 PchB is an intertwined alpha-helical dimer. Each monomer is composed of three alpha 
helices connected by loops [27] (Figure 2-3). There are two active sites per dimer and 
each active site contains catalytically important residues from both monomers [27] 
(Figure 2-4). PchB is a structural homolog of E. coli chorismate mutase and shares 
approximately 20% sequence similarity with the AroQ family of chorismate mutases [24] 
(Figure 2-5). In the only available structure of E. coli chorismate mutase an oxabicyclic 
transition state analog is bound in the active site[28]. This transition state analog is 
stabilized in the active site by eight charged or polar amino acids[28]. In PchB five of 
those residues (R14, R31, K42 R53 and Q90) are conserved [27, 28]. Therefore it is not 
surprising that PchB is able to catalyze the chorismate mutase reaction, albeit 
inefficiently. 
One of these five residues, the lysine at position 42, homologous to lysine 39 in E. coli 
chorismate mutase, is located in the flexible active site loop that opens and closes upon 
substrate binding and product release[27]. This flexible loop has been found to be 
disordered in the crystal structures determined without ligand in the active site but 
ordered in structures were the ligand is bound in the active site [27] (Figure 2-6). 
Moreover, based on the ligand bound structures it has been hypothesized that the 
positive charge of the lysine at position 42 would be able to interact, and stabilize, the  
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Figure 2-3: Structure of PchB with pyruvate and salicylate bound in the active site 
(PDB code 3REM, Olucha et al Biochemistry, 2011). PchB is an intertwined dimer, 
with monomers (displayed in raspberry red and purple) composed of 3 alpha helices 
connected by loops. There are two active sites per dimer containing residues from each 
monomer, and a flexible loop that has been proposed to open and close on the active 
site upon substrate binding and product release.    
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Figure 2-4. Stereo view of the PchB active site. There are 5 charged/polar residues 
in the PchB active site considered important for catalysis. Arginines 31, 53 and 14 from 
the second monomer, orient the substrate into the correct conformation in the active 
site, interacting with the carboxylates. The glutamine at position 90 and in particular the 
lysine at position 42 are poised to stabilize the developing negative charge of the ether 
oxygen at the transition state.     
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Figure 2-5: Overlay of E. coli Chorismate Mutase with PchB. E. coli chorismate 
mutase (EcCM, PDB code 1ECM, burgundy red) shares about 20% sequence identity 
with PchB (PDB code 3REM, gold). A structural overlay of both enzymes shows that 
they are structurally also very similar, with an R.M.S.D. of 1.06 Å over 242 Cα (dimer). 
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Figure 2-6: Overlay of structure of PchB without ligand in the active site and 
structure of PchB with salicylate and pyruvate in the active site. The active site 
flexible loop is flexible and highly mobile without ligand in the active site, but organizes 
upon ligand binding. Overlayed here are the “apo” (PDB code 2H9C, olive green) and 
salicylate and pyruvate bound (PDB code 3REM, burgundy red) wildtype PchB 
structures (without ligands for clarity). Circled in red, the active site loops. The active 
site loop of the “apo” structure (residues 42-49) could not be modeled for lack of density 
whereas it is very well defined and ordered in the ligand-bound structure.   
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partial negative charge of the ether oxygen at the transition state[24, 25, 27]. This 
hypothesis of electrostatic transition state stabilization juxtaposes to the hypothesis 
based on computational research done on E. coli chorismate mutase that suggests that 
only pre-organization of the substrate into a near attack conformation (NAC) is 
necessary for the reaction to occur. [29].  
2.2.4 Electrostatic Transition State Stabilization. 
Proponents of electrostatic transition state stabilization hypothesis argue that 
chorismate mutases, and by default PchB, derive their catalytic power from the 
stabilization of the transition state through complementary charges in the active site. 
One hypothesis to explain how chorismate mutases derive their catalytic power is 
electrostatic transition state stabilization (TSS).  Biochemical and computational data 
from several chorismate mutases supports this hypothesis [18, 30-34]. Mutational and 
computational work performed on the chorismate mutase of the Bacillus subtilis 
supports this hypothesis. Removal of the positive charge of the arginine at position 90, 
homologous to the lysine at position 39 of E. coli chorismate mutase and the lysine at 
position 42 of PchB, severely impairs catalysis[30, 33, 34]. Proponents of the idea that 
this positive charge is not important for catalysis, argue that Bacillus subtilis chorismate 
mutase research is not relevant to E. coli chorismate mutase because they are not 
structurally homologous (belong to the AroH, not the AroQ family of chorismate 
mutases). Mutational analyses of position 39 in E. coli chorismate mutase also show 
abolishment or severe decrease in activity when the lysine positive charge is removed. 
However, circular dichroism spectra of these mutants shows a shoulder at 210nm, 
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indicating that the secondary structure of the enzyme is affected by these mutations[34, 
35]. 
2.2.5 Near Attack Conformation 
The near attack conformation hypothesis is supported by high level quantum 
mechanical/molecular mechanical (QM/MM) modeling simulations. This model predicts 
that the formation of a near attack conformation of the ligand while still at the substrate 
level is enough to lower the activation energy barrier and the reaction occurs 
spontaneously[36]. The near attack conformation is generally described as a structure 
in which the reacting atoms are within van der Waals contact and approach at an angle 
15° to the bond that is formed, in an orientation in which the π-orbitals overlap[36]. This 
hypothesis predicts that once this conformation is achieved the reaction will occur 
spontaneously without electrostatic stabilization of the transition state or steric 
strain[36]. 
2.2.6 Combination of Both 
A third hypothesis proposed by Dr. AJ Mulholland from the chemistry department at the 
University of Bristol suggests that neither model of electrostatic transition state 
stabilization nor near attack conformation is entirely correct but rather the catalytic 
power of chorismate mutases (his model was B. subtilis chorismate mutase) is derived 
from combination of both[37]. This hypothesis is supported by QM/MM calculations at 
high levels of QM theory and some of the mutational work performed in our lab. Our 
mutational work shows that the alanine mutant at position 42 of PchB still conserves 1% 
of both isochorismate-pyruvate lyase activity and chorismate mutase[38]. This indicates 
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that in spite of a lack of positive charge at that position catalysis can still happen. The 
research presented in this dissertation investigates the role of the positive charge at 
position 42 using mutational analysis, pH profiles, chemical rescue, and computational 
analyses. 
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Chapter 3: pH Dependence of PchB Catalysis 
The work discussed in this chapter has been published as the following research 
articles: 
Luo, Q., J. Olucha, and A.L. Lamb, Structure-function analyses of isochorismate-
pyruvate lyase from Pseudomonas aeruginosa suggest differing catalytic mechanisms 
for the two pericyclic reactions of this bifunctional enzyme. Biochemistry, 2009. 48: p. 
5239-5245. 
and  
Olucha, J., et al., pH Dependence of catalysis by Pseudomonas aeruginosa 
isochorismate-pyruvate lyase: implications for transition state stabilization and the role 
of lysine 42. Biochemistry, 2011. 50(33): p. 7198-207. 
 
3.1 Introduction 
PchB is an isochorismate-pyruvate lyase. Its physiological function is to catalyze the 
breakdown of isochorismate into salicylate and pyruvate[1]. As described in Chapter 2, 
the salicylate produced by PchB is incorporated into the siderophore pyochelin via non-
ribosomal peptide synthetases [2]. PchB is also able to catalyze a second non-
physiological chorismate mutase reaction, generating prephenate from chorismate [1], 
albeit at a much lower catalytic efficiency. Both of these reactions are pericyclic: bond 
breaking and bond forming happen in a concerted fashion, resulting in a partially 
aromatic transition state with cyclic geometry [3-7]. The lyase reaction in PchB 
catalyzes a quantitative hydrogen transfer from C2 to C9 (Figure 3-1a), resulting in a 
somewhat unusual pericyclic transition state  with a hydrogen forming part of the cyclic 
structure (Figure 3-1a, IPL TS) [3]. The chorismate mutase pericyclic reaction on the 
other hand,  is a Claisen rearrangement of chorismate to prephenate,  transferring the  
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Figure 3-1: The two pericyclic reactions catalyzed by PchB: (a) isochorismate-
pyruvate lyase is a quantitative hydrogen transfer from C2 to C9 and (b) chorismate 
mutase is a Claisen rearrangement with a shift of the enol-pyruvate tail from C3 to C1.  
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enolpyruvate tail from the C3 ether to a C1-C9 bond (Figure 3-1b). The ability of PchB 
to catalyze two pericyclic reactions in the same active site makes this enzyme an 
interesting model to investigate the catalytic driving mechanism of pericyclic reactions.  
As described in Chapter 2, there is an ongoing debate in the field regarding the 
mechanism driving pericyclic reactions. On one hand, it has been proposed that the 
enzyme’s active site behaves as a vessel that orients the substrate into an orientation 
where reactive atoms are at van der Waals contact with each other and approach at an 
angle 15° to the bond that is to be formed, in an orientation in which the π-orbitals 
overlap[7-12]. On the other hand, it has also been proposed that it is not a near attack 
conformation but electrostatic stabilization of the transition state through the polar and 
charged residues in the active site which orient the substrate and stabilize the 
developing charges of the transition state (Figure 3-2) that drive the reaction forward [4-
6, 13-19]. In E. coli chorismate mutase (EcCM), the structural homolog of PchB, lysine 
39 was hypothesized to play such a role. In order to test the electrostatic transition state 
stabilization hypothesis, Liu and colleagues  performed a mutational analysis of the 
active site in which mutations to the lysine 39 resulted in 106 fold loss in catalytic 
efficiency [16]. However, the mutation resulted in a circular dichroism spectrum  slightly 
different from that of wild type, which indicated secondary structure was also affected by 
the mutation. Fortunately, mutations on the homologous residue in PchB (lysine 42) 
result in a similar loss of catalytic efficiency without disruption of secondary structure 
(Figure 3-3a) or active site architecture (Figure 3-3b) [20, 21]. Furthermore, the crystal  
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Figure 3-2: Stereo view of a snapshot of the PchB active site, from a QM/MM 
trajectory of the lyase reaction. The K42 is oriented such that the positive charge will 
stabilized the developing charge of the ether oxygen of the transition state. The QM/MM 
work will be presented in Chapter 5.   
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Figure 3-3: Mutations at position 42 do not affect secondary structure or 
architecture of the active site. (a) Circular dichroism spectra of mutants overlaid over 
wild type PchB [22]. All mutants display the same alpha-helical secondary structure. (b) 
Overlay of the active sites of wild type (white), K42E (light gray) and K42A (dark gray).   
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structure of wild type with two pyruvates in the active site shows lysine 42 hydrogen 
bonding with one of the  pyruvate molecules and potentially poised to stabilize the 
developing negative charge of the ether oxygen in both lyase and mutase transition 
states (Figure 3-3b) [23].   For these reasons PchB is a good model to investigate the 
relative contributions of the near attack conformation and electrostatic transition state 
stabilization. In order to investigate the role of the positive charge of the lysine in both 
lyase and mutase activities, a lysine to histidine mutant was generated. Histidine is the 
only proteogenic amino acid with a side chain pKa value  within physiological pH range 
(pKa = 6.1) [24]. Noting that the pKa value of the imidazole ring will be altered slightly 
depending on the environment [25], I hypothesized that below a pH value of 6, I would 
expect the histidine population shift towards both amino groups of the imidazole being 
protonated, and thus positively charged, whereas at pH value above 6, the histidine 
population would shift towards a neutral, unprotonated  state (Figure 3-4) [24]. In PchB 
K42H, therefore I would expect to see pH indepence of both chorismate mutase and 
isochorismate-pyruvate lyase activites if charge-independent near attack conformation 
is a more important contributor to catalysis (Figure 3-5a).  On  the  other  hand,  if  the  
contribution of the electrostatic transition state stabilization is more important for 
catalysis, I would expect to see pH dependence of both activities as pH increases 
above from the pKa value of histidine (Figure 3-5b).  
3.2 Materials and Methods 
3.2.1 Protein preparation 
Wild-type PchB without a histidine tag was prepared as previously described [26].  
K42H-, K42A- and K42E-PchB were prepared as previously described [27]. 
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Figure 3-4: Stereo view of QM/MM model of PchB K42H active site. At higher pH, 
the deprotonated histidine will have a neutral charge (a). At lower pH, the histidine will 
be protonated and positively charged (b).   
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Figure 3-5 Hypothetical pH profiles of PchB K42H lyase and mutase activities. If 
the NAC is the prevalent contributor to catalysis both lyase and mutase activities will be 
independent of pH (a). If electrostatic transition state contributes more to catalysis both 
lyase and mutase reactions will show dependence to pH.  
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3.2.2 Preparation of isochorismate and chorismate 
Isochorismate was isolated from K. pneumoniae 62-1 harboring the entC plasmid pKS3-
02 [28] with only minor changes, as described previously [27].  Chorismate (Sigma, 60-
80% pure) was recrystallized as previously described [29].   
3.2.3 Measurement of isochorismate-pyruvate lyase initial velocities  
 Initial velocities for the production of salicylate were recorded at pH values from four to 
nine in steps of one pH unit for wild-type, K42H, K42A and K42E-PchB.  A 
multicomponent buffer system was used to provide a constant ionic strength of 100 mM 
and to minimize salt effects: 50 mM formate, 50 mM MES, 100 mM TrisHCl, and 
adjusted to the appropriate pH with HCl or NaOH [30].   All reactions were carried out at 
room temperature (25 °C) with 5.3 mM enzyme (wild-type or mutant), incubated in buffer 
for 10 min, and initiated with the addition of 150 mM isochorismate (saturating 
conditions) with a total reaction volume of 100 mL.  The reactions were monitored for 50 
s by the increase in fluorescence using an excitation wavelength of 300 nm, and 
emission wavelength of 430 nm using Cary Eclipse fluorescence spectrometer (Varian).  
Data were plotted using Kaleidagraph (Synergy Software). 
3.2.4 pH Dependence of the Kinetic Parameters for the Isochorismate-
pyruvate Lyase Activity 
 Kinetic parameters for isochorismate-pyruvate lyase activity of wild type and K42H-
PchB were determined at pH values from 3.5 to 9.5 in steps of 0.5 pH units using the 
formate/MES/TrisHCl buffer described above.  All reactions were carried out at room 
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temperature with 1.5 mM enzyme (wild type or mutant) incubated in buffer for 10 min, 
and initiated with the addition of 0.1 mM – 0.4 mM isochorismate.  Product formation 
(initial velocity) was linear over the course of the experiment for all pH values tested.  
kcat and Km were calculated using SigmaPlot (SSPS, Inc.) and Kaleidagraph (Synergy 
Software).  
3.2.5 pH Dependence of the Kinetic Parameters for the Chorismate 
Mutase Activity  
Kinetic parameters for chorismate mutase activity of wild type and K42H were 
determined in the formate/MES/TrisHCl buffer described above, at pH values ranging 
from 3.5 to 9.5 in steps of 0.5 pH units (however, there was no measurable activity over 
pH 8), and pH 7.0 to 8.0 in pH steps of 0.1.  Protein concentrations varied per 
experiment from 90 µM to 900 µM per 100 mL run, with protein concentration increasing 
with pH, to optimize the signal-to-noise ratio.  Reactions between pH 3.5 and 7 were 
carried out at room temperature.  Temperature was kept constant for reactions from pH 
7.0 to 8.0 using a Quantum Northwest TC 125 temperature controller set at 25° C.  
PchB wild-type and PchB K42H were incubated in the buffer for 10 minutes before each 
reaction. Reactions were initiated by the addition of the chorismate at concentrations 
ranging from 0.1 mM to 5.0 mM, and were mixed using a micropipette tip before placing 
the cuvette in the spectrophotometer.  Initial velocities were determined by measuring 
the disappearance of chorismate at 310 nm (Figure 3-6,  ε310 = 370 M-1 cm -1) using a 
UV Spectrophotometer (Cary 50 Bio, Varian).  Substrate consumption was linear over 
the course of the experiment for those pH values that showed detectable activity.  
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Michaelis-Menten kinetic data were fit by nonlinear regression.  For experimental 
conditions at pH 7.5 and above, substrate concentrations were sub-saturating; 
therefore, kinetic constants were determined using Henderson and Dixon plots [31].  All 
data were fit using KaleidaGraph (Synergy Software) or SigmaPlot (SSPS, Inc.).   
3.2.6 Data analysis for pH studies 
 pH profiles of kcat and kcat/KM values for substrates were fit to equations 1-4.  Plots for 
which the log of the parameter decreased at acidic pH with a slope of 1 were fit with 
equation 1: 
 
 
Profiles in which the log of the plotted parameter decreased with a slope of 1 at acidic 
pH and decreased with a slope of -1 to a lower plateau value at basic pH were fit to 
equation 2: 
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Figure 3-6: Sample Initial velocities of the chorismate mutase at selected pH 
values.  PchB is a poor chorismate mutase, and in order to measure a linear initial 
velocity through a reasonable time period for all pH values, the assay conditions and 
buffer had to be optimized.  
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Profiles in which the log of the plotted parameter decreased at basic pH with a slope of 
2 were fit to equation 3:                                                                
 
 
 
Profiles in which the plotted parameter decreased at acidic pH with a slope of 1 and 
decreased at basic pH with a slope of 2 were fit to equation 4: 
 
 
 
 In equations 1-4, Y is the observed value (kcat or kcat/KM), c is a pH independent plateau 
value of Y, YL is a plateau value of Y at low pH, YH is a plateau value of Y at high pH, H 
is the proton concentration, and Ka1, Ka2 and Ka3 are the apparent dissociation constants 
for groups on the enzyme or substrate.  Any data represented as a straight line is a 
simple linear regression. The pKa values and kinetic constants can be seen in Table 3-
1.    
3.2.7 Calculation of DDG¹ 
The “mutational effect” was determined by dividing kcat/Km value of the mutant enzyme 
by that of the wild type, as done previously [27].  The DDG‡ was calculated from the 
equation:  
DDG‡ = -RT ln (mutational effect) 
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Table 3-1: pH profiles for wild type and mutant PchB1 
Activity  Enzyme  Kinetic 
Parameter 
pK values and kinetic 
constants 
 Titratable 
group 
Lyase         
  WT  kcat c 0.90 ± 0.01   
     pKa1 2.78 ±0.02  substrate 
         
    kcat/Km c 4.17 ±0.09   
     pKa1 2.79 ± 0.08  substrate 
         
         
  K42H  kcat YL 0.75 ± 0.02   
     YH 0.03 ± 0.07   
     pKa1 3.04 ± 0.00  substrate 
     pKa2 6.65 ± 0.13  His 42 
         
    kcat/Km YL 3.40 ± 0.01   
     YH 1.90 ± 0.00   
     pKa1 3.00 ± 0.01  substrate 
     pKa2 6.29 ± 0.00  His 42 
         
         
Mutase         
  WT  kcat/Km c 2.01 ± 0.1   
     pKa1 2.7 ± 0.0  substrate 
         
         
  K42H  kcat c 0.6 ± 0.1   
     pKa1 3.6 ± 0.0  substrate 
     pKa2 7.7 ± 0.0  His 42 
     pKa3 8.5 ± 0.1  ? 
         
    kcat/Km c 1.3 ± 0.2   
     pKa1 9.0 ± 0.6  ? 
     pKa2 6.1 ± 0.4  His 42 
         
 1 Table adapted from Olucha et al, 2011 [21] 
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3.3 Results 
3.3.1 Initial velocity of wild type, K42E, K42A and K42H 
To determine the viability of the experiment I determined the overall pH profile of wild 
type PchB and mutants K42A K42E and K42H (Figure 3-7). lyase activity was 
determined by fluorescence, measuring production of the salicylate (ex 310 em 430)  at 
saturating concentrations of isochorismate over range of pH values from pH 4 to pH 9. 
As described in previous work the K42E mutant displayed no activity throughout the pH 
range. Wild type PchB and K42A mutant displayed pH independent initial velocities 
throughout the pH range. On the other hand, the K42H mutant displayed the pH 
dependence of initial velocities throughout pH range as expected from the theoretical 
pKa value of the histidine side chain.  
3.3.2 pH dependence of lyase activity 
To determine the catalytic constants of the lyase activity from a pH value of 3.5 to a pH 
value of 9.0, I used a multi-component buffer system that would allow me to buffer the 
solution at all the desired pHs as well as maintain a constant ionic strength along the pH 
range without interfering with the fluorescence of salicylate. Kinetic parameters for wild 
type and mutant enzymes were determined throughout pH range in steps of 0.5 pH 
units. The kinetic parameters were plotted as a function of pH and fitted to equation 2. 
(Figure 3-8). As expected wild type PchB showed independent catalytic activity  
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Figure 3-7: pH dependency of mutants K42A, K42E, and K42H overlayed over wild 
type PchB. Only PchB K42H displays pH dependency of catalytic activity along the 
whole pH range.    
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Figure 3-8: pH dependence of isochorismate-pyruvate lyase activity kcat and 
kcat/Km.  Both kcat and kcat/Km show pH dependence. The decrease in activity at the 
lower pH values is most likely the result of an ionizable group in the substrate (pKa 
value ~3). Decrease in activity at higher pHs is indicative of a single ionizable group with 
a pKa value ~ 6.5, which agrees with the theoretical pKa value of the histidine. At higher 
pHs, the activity once again becomes pH independent, suggesting electrostatic 
transition state stabilization is not the only driving mechanism for the reaction.   
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throughout the pH range except for a decrease in activity at lower pH values with a 
slope of 1.0. This indicated a single protonation/deprotonation event with a calculated 
pKa values of 2.78 ± 0.02 or 2.79± 0.08 depending on whether kcat or kcat/Km were used 
for the calculation. This pKa value can be attributed to the protonation of the 
isochorismate carboxylates which have a theoretical pKa value of approximately 3.6 
[32]. The K42H mutant on the other hand while showing activity throughout the pH 
range showed pH dependent variability up to a pH value of 7, displaying the same 
decrease in activity as wild type PchB at pH values under 4.5, a peak in activity at pH 
value of 5.0 and a decrease with a slope of -1 to pH 7. Above pH 7 catalytic efficiency 
remain constant up to pH 9 albeit an order of magnitude less than the peak pH 5.0, and 
two orders of magnitude less than wild type . The decrease in activity at low pH values 
is comparable of that to wild type, again a single ionizable group (slope = 1) with a pKa 
value of 3.04± 0.00 (kcat) or 3.00± 0.01(kcat/Km) corresponding to the carboxylates of the 
isochorismate. The decrease of slope -1 between pH values 5.0 and 7.0 corresponds to 
a second ionizable group with a calculated pKa value between 6.65 ± 0.13 it calculated 
from the kcat or 6.29 ± 0.00 if calculated from the kcat/Km. This pH value dependent 
variation in catalytic activity is not observed either in wild type PchB or the other two 
mutants tested. This together with the calculated pKa values very close to the 
theoretical histidine pKa value of  6.1  indicate  that  we  are  observing  a  decrease  in  
catalytic activity as we shift the population of enzyme from positively charged histidine 
at low pH values to neutral histidine at higher pH values. However in spite of the 
significant decrease in activity, activity is still observable at pH values where the 
67 
 
population of enzyme is almost completely shifted towards neutral charge, indicating 
catalysis independent of the positive charge at that position.  
3.3.3 pH dependence of PchB mutase activity 
Wild type PchB showed pH value independent mutase activity throughout the pH range 
from 3.5 to 9.5. As with the lyase activity the mutase catalytic efficiency of wild type 
PchB showed a decrease in activity at lower pH values with a slope of 1 at low pH 
values with a pKa value of 2.7 ± 0.0 (Figure 3-9). This corresponds to the theoretical 
pKa value of the carboxylates of chorismate calculated at 3.6. This carboxylate needs to 
be deprotonated for efficient catalysis. PchB K42H mutase activity showed pH 
dependence at high pH values, and we were unable to detect activity at pH values 
above 7.8. Again turnover was highest at pH value 5.5. Unlike the lyase activity, fitting 
the turnover data to equation 4 indicated a decrease in activity with a slope of -2 as pH 
was increased, suggesting that we are observing not one but two ionizable groups, one 
with a pKa value value of 7.7 ± 0.0 and a second group with a pKa value value of 8.5 ± 
0.1. The catalytic efficiency pH profile of the mutase activity also indicated two ionizable 
groups necessary for catalytic activity with pKa value's of 9.0 ± 0.6 and 6.1 ± 0.4. As in 
the lyase activity data, we can attribute the pKa with values of 7.7 (kcat) and 6.1 (kcat/Km) 
to the histidine in the active site.  
3.4 Discussion  
Two models have been proposed to explain the molecular mechanism that drives 
pericyclic reactions in chorismate mutases and by extension PchB’s lyase and mutase 
activities. On one hand, it has been proposed that two arginines buried within the active 
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site of the enzyme orient the substrate into the correct position, and the enzyme acts as 
a container, promoting the substrate to conform to a particular shape, the near attack 
conformation, or NAC. Once the substrate conforms to this shape, the reaction goes 
forward[7, 18]. On the other hand, it has been proposed that charged or polar residues 
in the active site stabilize the transition state by complementing the transition state’s 
developing charges. Mutations of lysine 39 in EcCM abolished activity, but also 
disrupted secondary structure. Mutations of the homologous residue in PchB, lysine 42, 
also impair catalysis, but do not disrupt secondary structure, or alter the architecture of 
the active site, making PchB an excellent model to study the molecular mechanism in 
these enzymes. Mutating the lysine to a histidine at position 42 lowers the pKa value at 
that position. This enables us to observe the effects of shifting the H42 population from 
protonated (positively charged) to deprotonated (neutral) within a physiological pH 
range within the same enzyme. The model proposing that the formation of a NAC is 
enough to lower the energy barrier predicts that we would observe pH independent 
catalysis throughout the pH range, both for wild type PchB and the K42H mutant, 
because the charge at position 42 is not required for catalysis (Figure 3-5a). However, 
the electrostatic transition state stabilization model predicts the opposite, a pH 
dependent decrease in catalytic activity as the H42 population is shifted to neutral 
(Figure 3-5b).  
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Figure 3-9: pH dependence of chorismate mutase activity kcat and kcat/Km.  Both kcat 
and kcat/Km show pH dependence. Decrease in activity at the lower pH values most 
likely the result of an ionizable group in the substrate (pKa value ~3), comparable to that 
observed in the lyase activity. Decrease in activity at higher pH values is indicative of a 
two ionizable groups with pKa values ~ 6.1-7.7 (whether determined from kcat/Km or kcat, 
respectively), and a second pKa value of ~9.0. The first pKa value agrees with the 
theoretical pKa value of the histidine. The second pKa value most likely corresponds to 
an ionizable group further away from the active site, with an effect small enough not to 
be observable in the physiological lyase activity, but clearly observable in the already 
poor mutase activity. Unlike the lyase activity, there is no observable mutase activity 
past pH value 7.8.  
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3.4.1 PchB Lyase activity 
The isochorismate-pyruvate lyase activity of wild type PchB showed a constant, pH 
independent catalytic efficiency throughout the pH range, as expected. Only at pH 
values below 4.5 was a drop in activity observed. This would either correspond to the 
protein beginning to unfold, or a protonation/deprotonation event necessary for 
catalysis. The inflexion point of this event at  pH value ~3, approximately corresponds to 
the pKa value of the carboxylates of the isochorismate (pKa = 3.6). Protonation of these 
carboxylates would alter their interaction with the active site arginines that orient the 
substrate into its correct position for catalysis. This drop is observed for both, wild type 
and K42H mutant, indicating that the same protonation event is occurring for both 
enzymes. As predicted by the electrostatic transition state stabilization model, we 
observed a decrease in activity corresponding to a single protonation event (slope = -1) 
and a pKa value closely approximating the pKa value of the histidine.  However, past 
pH value 7.5, catalysis becomes once again pH independent, albeit approximately an 
order of magnitude lower than at its peak at pH value 5. Although electrostatic transition 
state stabilization is necessary for efficient catalysis, another catalytic model, possibly 
the NAC formation, is sufficient for inefficient, but detectable catalysis.  
3.4.2 Mutational effects and free energy contributions to lyase activity 
In order to determine the individual contribution of the positive charge at position 42 to 
catalysis the data can also be interpreted in terms of mutational effects and differences 
in free energies of activation. To calculate the contribution of the positive charge to 
catalysis, we first need to determine the contributing effect of the mutation from lysine to 
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histidine.  At the peak of K42H catalytic efficiency, (between pH values 5 and 5.5), the 
mutational effect (( ⁄ ) ( ⁄ )⁄ ) is approximately 0.2, representing a 
ΔΔG‡ of 1.0 kcal/mol. This difference in energy can most likely be attributed to the 
difference in shape and size between the lysine in the wild type PchB and the histidine 
of the K42H. At pH value 9, when most of the K42H enzyme population is deprotonated, 
a mutational effect of 0.003 represents a ΔΔG‡ of 3.4 kcal/mol. This number includes 
the contribution of the positive charge and sidechain shape and size. Subtracting the 
effect of the mutation (1.0 kcal/mol) results in a ΔΔG‡ contribution of 2.4 kcal/mol, 
agreeing with the previously reported mutational effect for the K42A mutant of 2.7 
kcal/mol [20].    
3.4.3 PchB mutase activity 
Chorismate mutase activity in PchB was not covariant with the lyase activity. As was 
observed in the lyase data, the mutase activity decreased with a slope of 1 at lower pH 
values, suggesting once again an ionizable group (a carboxylate) from the substrate 
affecting catalysis. At the peak of catalytic activity, between pH values 5 and 6, K42H 
exhibits higher turnover than wild type PchB. Unlike the lyase activity, there is no 
detectable activity past pH value 7.8, and the data fit a model with two ionizable groups, 
one at a pKa value 6.1 (kcat) or 7.7 (kcat/Km) and the second with a pKa value of ~9. The 
first ionizable group agrees with the theoretical pKa value of the histidine sidechain, and 
agrees with the lyase activity. The second pKa value however might correspond to one 
of the arginines in the active site, (theoretical pKa value ~12, albeit lowered in the active 
site environment). The ionization state of these arginines would be essential for the 
correct orientation of the substrate in the active site, as they hydrogen-bond to the 
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substrates’ carboxylates. Another option is that this phenomenon is not caused by an 
ionizable group in the active site, but a group further away, whose protonation state 
affects a hydrogen bond or a salt bridge. A small disruption in the enzyme’s structure 
might not affect the physiological lyase activity (this observation is not observed in the 
lyase activity), but the poorer chorismate mutase activity might be more sensitive to 
such a small disruption. 
3.5 Conclusions 
Previous mutagenesis experiments showed that lysine 42 is important for catalysis, with 
evidence supporting electrostatic transition state stabilization as essential for efficient 
catalysis. However, the K42A mutant still displayed about 1% of wild type lyase activity, 
and the pH profile of K42H at high pH values shows similar activity, indicating that lyase 
catalysis still occurs at an observable rate without a positive charge at position 42. 
Electrostatic transition state stabilization is essential for efficient catalysis, but some 
other mechanism (a reactive substrate conformer?) is sufficient for (albeit inefficient) 
catalysis. As with the lyase activity, the data indicate that the positive charge at position 
42 is important for catalysis, supporting the electrostatic transition state stabilization 
hypothesis. However, there is no observable catalysis at a point where the majority of 
the enzyme (>75%) population has lost the positive charge at that position.  This would 
indicate that unlike the lyase activity, in PchB, electrostatic transition state stabilization 
is essential for observable catalysis.  
Lyase and mutase activities had been suggested to be concomitant with electrostatically 
and geometrically similar transition states, based on mutational analyses of Q90 [3] in 
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which pH profiles showed a titration of activity with Km not kcat.  If  this  were  true,  we  
would have observed the same trends in the lyase and mutase data for K42H, which is 
not the case. The positive charge of the lysine contributes differently to lyase and 
mutase reactions. Furthermore, observable lyase activity at high pH values indicates 
that there might be multiple catalytic pathways, at least two, for the lyase activity. This 
“catalytic network”, already proposed for other enzymes by Benkovic, would indicate 
that instead of a two dimentional energy coordinate, there are multiple pathways in a 
three-dimentional energy landscape that would lead to catalysis. This leads to the 
hypothesis that protein motions are important for catalysis. This hypothesis will be 
explored in Chapter 4 (Chemical Rescue) and Chapter 5 (QM/MM Simulations).        
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Chapter 4: Chemical Rescue of Isochorismate-Pyruvate Lyase Activity 
of PchB 
4.1 Introduction 
 
Chemical rescue is a widely accepted enzymology tool that allows a more detailed 
analysis of specific sidechains in an active site [1-6]. The most commonly used 
chemical rescue technique involves non-covalent rescue (Figure 4-1); an alanine 
mutant is generated at the position the researcher is interested in and excess 
compound mimicking the lost side chain (e.g. propylamine to mimic a lysine in Figure 4-
2b [5, 6] or imidazole to mimic a histidine [7]). In excess, the compound will fill the void 
left by the mutated residue in a percentage of the enzyme, thus rescuing lost catalytic 
activity in that enzyme population.   
Alternatively, mutation of the residue of interest to cysteine allows for covalent chemical 
modification [2, 3] via alkylating agents (chemical reaction in Figure 4-3 e.g. 
bromoethylamine to generate γ-thio lysine, Figure 4-2c ; This scheme shows the 
modification by bromoethanol in Figure 4-2d, which will also be used in this work). 
Covalent modification allows for better control over the position and orientation of the 
rescue mimetic, with the caveat that any other reactive cysteines may be modified as 
well. 
Previous work on E. coli chorismate mutase [8-13] suggest that a positive charge at 
position 42 is not essential for efficient catalysis, as long as the substrate organizes into  
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Figure 4-1: Chemical Rescue Overview. (A) Enzyme (blue C-shape) has residue of 
interest buried in the active site (star shape). This particular enzyme catalyzes a lyase 
reaction breaking down a compound (red cylinder-cube shape) into its components.  (B) 
A mutant generated without the residue of interest is no longer able to catalyze the 
reaction. (C) If an exogenous compound mimicking the missing side chain is added to 
the solution in high enough excess, a percentage will find its way to the void left by the 
missing catalytic side chain, restoring catalytic activity, at least partially in this 
population of enzyme.    
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Figure 4-2: Comparison scheme of the different chemical rescues as compared to 
wild type lysine. Wild type lysine (a); propylamine rescue of the K42A mutant (b), and 
γ-thiolysine, and 3-(2-hydroxyethyl)-thio-cysteine (d) rescue of the K42C mutants. 
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Figure 4-3: Cysteine alkylation reaction. In a high pH environment, SH is in 
equilibrium with the deprotonated form (S-). The S- performs a nucleophillic attach on 
the bromoethylamine, with a release of the Br- as the leaving group.    
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a near attack conformation via interaction of its carboxylates with two buried arginine 
residues. However, mutational analyses and pH dependence studies of PchB have 
shown the positive charge at position 42 is necessary for efficient salicylate production 
(previous chapter and references [14, 15]) In these studies, the positive charge is 
hypothesized to stabilize the developing negative ether oxygen at the transition state, 
[16-19] analogous to work with E. coli  chorismate mutase [18, 20, 21] .  Crystal 
structures of PchB with and without product in the active site [22] reveal that K42 is 
located in a flexible loop that closes the active site upon substrate binding and opens as 
product is released. In addition, thermodynamic experiments have led to the hypothesis 
that organization of the loop is an energetically important step in catalysis [23]. The 
chemical rescue experiments described here provide further evidence that the positive 
charge at position 42 is important for catalysis and provide validation for the hypothesis 
that loop organization is also important: only covalent modifications of PchB variants 
with lysine mimetic alkyl-amines are able to rescue catalytic efficiency.  
4.2 Materials and Methods 
4.2.1 Protein Preparation.  
 
Wild Type PchB was prepared as previously described [22]. Site directed mutants of 
PchB were prepared using the plasmid used for wild type PchB overexpression as the 
template and Quickchange II (Agilent) mutagenesis kit, protocol as per manufacturer’s 
instructions. K42C mutation was generated using primer of sequence:   
5’-GGCGTCGCGCTTCTGCGCCAGCGAGGCGG-3’   
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 and its reverse complement. C07A mutation was generated using primer of sequence:  
5’-AACTCCGAAGACGCCACCGGCCTGGCG-3’  
and its reverse complement. 
In order to prevent disulfide bond formation and aggregation of the mutants during 
purification, 20mM β mercapto-ethanol was added to the resuspension buffer. All 
buffers used in the purification process, including 30Q and gel filtration buffers 
contained 1mM TCEP (Sigma). 
4.2.2 Enzymatic Assays. 
 
All assays were performed using a TgK Scientific Stopped Flow device, with a xenon 
lamp emitting at 310 nm, and a 360 nm cutoff filter. Equal 50µl volumes of enzyme and 
substrate were injected into a 22 µl cell and initial velocity of salicylate production was 
measured as an increase in fluorescence at 430 nm for 30 seconds (during which the 
reaction was linear). Pre-injection enzyme and substrate concentrations were twice the 
final enzyme/substrate concentration in the cell (post mixing). Unless otherwise 
specified, all concentrations reported are final post-mixing concentrations. Both 
substrate and enzyme were prepared in the same buffer system to prevent buffer 
dilution effects post mix. Substrate was prepared from a stock of 4.8 mM isochorismate 
into 0 µM to 400 µM concentrations. Enzyme concentration ranged from 100 nM for 
Wild Type PchB experiments to 1 µM for PchB K42C and C07A/K42C experiments. 
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Michaelis-Menten kinetic data were fit using Kaleidagraph (Synergy Software) using 
non-linear regression. All catalytic constants can be seen on Table 4-1      
4.2.3 Chemical Rescue of K42A by Propylamine 
 
PchB K42A (1 µM) was incubated for 45 minutes on ice in 50 mM Tris HCl pH 8.0, 
150mM NaCl, 10% Glycerol, 1mM TCEP buffer, with and without 500 mM chemical 
rescue agents of varying carbon chain length (Figure 4-4). Substrate used for either of 
the experiments was prepared with the same buffer components, including 500 mM 
propylamine (to maintain propylamine concentration post-mix).  
4.2.4 Covalent Chemical Rescue of single and double PchB cysteine 
mutants with Bromo-ethylamine and Bromo-ethanol.   
 
PchB mutants and controls were incubated for  22-24 hrs at 18° C in 10 mL  of 1 M Tris 
pH 8.8, 150mM NaCl, 10% Glycerol, 1mM TCEP buffer,  with and without 1 mM 
bromoacylating reagent added. After the incubation period, enzyme was concentrated 
using microcon centrifuge concentrators, and enzyme buffer was exchanged to 50 mM 
Tris HCl pH 8.0, 150mM NaCl, 10% Glycerol, 1mM TCEP to remove alkylating agent 
using a PD-10 desalting column (GE Healthcare) as per manufacturer’s specifications. 
Concentration measured via Bradford. Enzyme was added to 10 mL of reaction buffer 
without bromoacylating agent to final concentration of 200 nM – 20 uM (2X post-mix 
enzyme concentration).  Substrate was prepared with the same buffer components.  
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Table 4-1: Catalytic constants  
 Sample kcat (x103 s-1)  Km (µM) kcat/Km (M-1 s-1) 
WT Control 390 ± 10   1.5 ± 0.3 258,000 ± 5000 
PrA 110 ± 1  14.0 ± 0.1 7,700 ± 100 
BrEA 180 ± 1  9.7 ± 0.1 19,000 ± 100 
BrEtOH 85 ± 1  35.0 ± 0.1 2,500 ± 100 
      
K42A Control 23 ± 1  28.0 ± 0.4 850 ± 10 
PrA 39 ± 1  40.0 ± 0.1 970 ± 10 
      
K42C Control 1.0 ± 0.01  62.0 ± 0.7 15 ± 1 
BrEA 96 ± 1  63.0 ± 0.7 1,500 ± 20 
      
C7A,K42C Control 3.2 ± 0.1  63.0 ± 1.4  51 ± 1 
BrEA 98 ± 0  27.0 ± 0.7 3,700 ± 100 
BrEtOH 3.2 ± 0.2  98.0 ± 0.6 32 ± 1 
      
C7A Control 140 ± 1  2.1 ± 0.2 67,000 ± 6000 
BrEA 120 ± 1  1.6 ± 0.2 79,000 ± 2000 
BrEtOH 120 ± 1  2.9 ± 0.7 40,000 ± 2000 
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Figure 4-4: Chemical rescue of isochorismate-pyruvate lyase activity by the 
addition of exogenous alkylamine compounds of differing carbon chain length. 
No rescue of K42A activity was observed (red data, in plot a) with the addition of 
increasing concentrations of propylamine to the solution. Shorter or longer rescuing 
agent did not rescue catalytic activity either (b)  
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4.2.5 Ellman’s Reagent competition assay 
 
In order to determine whether the cysteine at position 7 was solvent accessible and thus 
alkylatable, 1 mL of 1mM protein sample (PchB WT; K42C; C7A or C7A,K42C, 
concentration determined by measuring absorbance at 280 nm) were incubated for 24 
hours at 18°C in the same buffer used in the alkylation process as described above, but 
without alkylating reagent.  
A volume of 100 µl of each of the samples was then allowed to react with 1 mM DTNB 
reagent in 300 mM Tris pH 8.0, 25 mM Sodium Acetate buffer for 5 minutes at room 
temperature. Absorbance was measured at 412 nm and concentration of NTB-2  was 
determined (ε=13600 cm-1 l-1 ) [24] . This concentration corresponds at a 1:1 ratio with 
the solvent accessible cysteines in solution.  
PchB WT and C7A mutant showed no change increase absorbance, indicating no 
cysteines are solvent accessible in these enzymes (Table 4-2).  
K42C and C7A,K42C both showed a similar absorbance change corresponding to only 
one cysteine (the cysteine at position 42) per protein molecule being solvent accessible. 
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Table 4-2: Percentage derivatization at position 42 
 
 Sample % alkyl-amination at pos. 42* 
WT Control 0% 
PrA 0% 
BrEA 0% 
BrEtOH 0% 
   
K42A Control - 
PrA - 
K42C Control 0% 
BrEA 82% 
   
C7A/K42C Control 0% 
BrEA 98% 
BrEtOH 100% 
   
C7A Control 0% 
BrEA 0% 
BrEtOH 0% 
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Samples of each enzyme were then incubated at the same concentration and the same 
incubation buffer as described above for the controls but with excess alkylating agent 
(10 mM). DTNB competition assay was performed as described above for the controls 
and percent alkylation for each of the alkylating agents (bromoethylamine and 
bromoethanol) was determined as   
1 −
[ 	 ℎ	 	 ]
[ 	 ℎ 	 	 ]
 
 
Using the concentrations as determined by DTNB assay (Table S3).  
4.2.6 Calculation of ΔΔG‡  
 
In order to quantify chemical rescue more effectively, variant effects were calculated in 
terms of changes in energies of activation: 
 
ΔΔG‡ = −RT	ln	[
(k K )⁄
(k K )⁄
] 
 
 Propagation of the error of  kcat/Km  to the  ΔΔG‡ was calculated as 
 
=
( / 		)
( / 		) +
( / 		)
( / 		)
ln( )
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4.3 Results and Discussion 
 
A lysine to alanine (K42A) mutation reduces catalytic efficiency to 1% of wild type (Table 
4-3 and ref. 1).  Similar (K→A) mutations in enzymes where the residue of interest is 
found deep within the active site have been successfully rescued using non-covalent 
binding of alkyl amines.[6, 25, 26] In other words, the non-covalent rescue agent, at 
high molar excess, binds in the void left by the  alanine mutation and is properly situated 
when substrate binds to promote catalysis.  The inability of propylamine at 105 molar 
excess to chemically rescue PchB K42A activity (Figures 4-5 and 4-6 and Table 4-2) 
suggests that the propylamine is not preorganized in the site of the K42A variant prior to 
substrate binding.  On the other hand, covalently modification of the K42C-variant of 
PchB with bromoethylamine to generate a lysine mimetic (Figures 4-5, 4-7 and Table 
4-2) successfully rescued catalytic activity by two orders of magnitude. In this case, the 
positive charge of the lysine mimetic is carried along during active site loop closure, 
thereby properly organizing the active site to stabilize the developing negative charge at 
the ether oxygen of the transition state.   Finally, to test whether the lysine sidechain is 
instead important in a steric sense, promoting loop organization and closure, as 
opposed to the necessity of a positive charge to promote efficient catalysis, the K42C-
varaint was modified with bromoethanol (Scheme 1D).  This variant is isosteric with the 
K42C-bromoethylamine but has the neutral alcohol instead of the charged amine 
terminating the sidechain.  This variant also provides a hydrogen bond that may  
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Table 4-3: Variational effects 
Rescue Agent Variational  Effect 
ΔΔG‡ (kcal mol-1) 
(-RTln [mut. effect]) % Rescue 
Controls    
 C7A/WT 0.78 ± 0.07  
 K42A/WT 3.32 ± 0.01  
 K42C/WT 5.66 ± 0.01  
 (C7A,K42C)/C7A 4.16 ± 0.03  
    
    
Propylamine  
(PrA) (K42A+PrA)/K42A -0.08 ± 0.07 2% 
    
    
    
Bromoethylamine (BrEA) (K42C+BrEA)/K42C -2.68 ± 0.02 48% 
 (C7A,K42C + BrEA)/  (C7A-K42C) -2.49 ± 0.01 60% 
    
    
Bromoethanol (BrEtOH) (C7A,K42C + BrEtOH)/ (C7A,K42C) 0.3 ± 0.2 -6% 
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Figure 4-5: Catalytic Efficiencies of the Chemical Rescues. PchB wild type (WT) 
controls in red, K42A experiment in green. Cysteine mutants C7A/K42C and K42C (in 
orange and yellow respectively). Addition of rescue agents to WT enzyme assays 
results in decrease activity, most likely due to unexpected interaction of the propylamine 
(PrA) with WT enzyme due to the excess PrA present in solution, or alkylation of the 
cysteine at position 7 by bromoethylamine (BrEA) and bromoethanol (BrEtOH). 
Propylamine  did not rescue catalytic efficiency in K42A mutant (green bars). However, 
covalent modification of the K42C to generate a lysine mimetic rescued 102  fold activity 
(top orange bar vs orange middle bar). In contrast bromoethanol (bottom orange bar), 
did not rescue activity. The C7A mutant was not significantly affected by the addition of 
the rescue agents.  
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Figure 4-6: Stereo view of propylamine K42A chemical rescue. The model of the 
active site with isochorismate is based on QM/MM minimized wild type PchB active site.  
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Figure 4-7: Stereo view of bromoethylamine K42C derivative (γ-thio-lysine). The 
model of the active site with isochorismate is based on QM/MM minimized wild type 
PchB active site.   
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Figure 4-8: Stereo view of bromoethanol K42C derivative (3-(2-hydroxyethyl)-
thiocysteine). The model of the active site with isochorismate is based on QM/MM 
minimized wild type PchB active site.   
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alternatively be important in catalysis (as opposed to charge).  This variant did not 
rescue lyase activity (Figure 4-5, 4-8 and Table 4-3. 
In order to quantify chemical rescue more effectively, mutational effects can be 
calculated in terms of changes in energies of activation (ΔΔGǂ , Table 4-3): 
 
ΔΔG‡ = −RT	ln	[
(k K )⁄
(k K )⁄
] 
 
where R is the gas constant (1.98x10-3 kcal  K-1 M-1) and T is the experimental 
temperature, 293 K (20°C).The mutational effect resulting from replacing the wild type 
lysine for an alanine at position 42 increases the free energy of activation by 3.32 kcal 
mol-1. This number represents the maximum that any chemical rescue agent could 
promote activity in this variant.  Adding 105 molar excess of propylamine does not 
significantly rescue activity (0.08 kcal mol-1 or 2% rescue of the mutational effect).  As 
stated before, this value suggests that the propylamine positive charge is not organized 
in the active site such that upon loop closure there is no rescue of catalysis.  
Replacing the wild-type lysine for a cysteine at position 42 contributes an additional 5.66 
kcal mol-1 to the free energy of activation as compared to wild type PchB. Covalent 
modification of the cysteine with bromoethylamine to form a lysine mimetic however, 
rescues by 2.68 kcal mol-1, which represents 48% rescue of the mutational effect. In 
other words, the covalently modified lysine mimetic is able to rescue the lyase activity 
because the positive charge contributing to catalysis is part of the active site loop that 
re-organizes with loop closure.   
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The decrease in catalytic efficiency of PchB WT treated with bromoethylamine as 
compared to PchB WT and may be due to  the  alkyl-amination of the  cysteine at 
position 7. In order to control for the effects of modification at the naturally occurring 
cysteine in PchB, the C7A mutant was generated. The K42C mutation over the C7A 
background (double mutant C7A,K42C) resulted in a mutational effect energy gain of 
4.16 kcal mol-1. Treatment with BrEA of the double mutant C7A,K42C rescued 2.49 kcal 
mol-1, 60% of the mutational effect. These results confirm the chemical rescue observed 
in the single mutant, K42C: covalent modification to generate a lysine mimetic at 
position 42 on the mobile active site loop rescues catalytic activity.  
In order to determine whether we could rescue catalytic activity through hydrogen 
bonding alone, and no positive charge at position 42, we generated a variant with a 
hydroxyl group in place of the amine at position 42, by treating the C7A,K42C double 
mutant with bromoethanol instead of bromoethylamine. Treatment with bromoethanol 
resulted in the opposite effect as observed with bromoethylamine treatment; an 
additional 0.27 kcal mol-1 increase in activation energy. A hydrogen bond donor at 
position 42 does not rescue catalytic activity as does the positive charge of the lysine 
mimetic.  
Previous mutagenesis[14] and pH dependence[15] experiments provided evidence that 
the positive charge at position 42 is important for efficient catalysis. The ability to rescue 
catalytic activity of the K42C variant through the generation of a γ-thio-lysine at position 
42, but not through the generation of the hydroxyl derivative, gives further support to the 
importance of electrostatic transition state stabilization in the isochorismate-pyruvate 
lyase reaction. Structural[22] and thermodynamic[23] experiments have led to the 
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hypothesis that loop dynamics are important for catalysis. Indeed, this is supported by 
the ineffectiveness of the propylamine as a non-covalent chemical rescue reagent; the 
positive charge must be organized with the loop for efficient catalysis. In sum, these 
results indicate that a positive charge at position 42 AND correct loop organization lead 
to efficient lyase catalysis, and give further support to the idea that electrostatic 
transition state stabilization and loop dynamics work in concert for catalysis.     
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Chapter 5: Computational Enzymology of PchB 
 
5.1 Introduction 
 
Computational chemistry is a branch of chemistry that uses principles of computer 
science to assist in solving chemical problems. Experimental and theoretical chemistry 
results are incorporated into in silico models to calculate the structures and properties 
of molecules and trajectories (calculated reaction pathway) of enzymatic reactions. 
Necessity for computational enzymology arises from the idea that some enzymology 
questions cannot be solved analytically. Most often, computational results complement 
the information obtained by chemical experiments, but in some cases virtual 
experiments are also able to predict unobserved chemical phenomena. Computational 
enzymology is widely used in the design of new drugs and materials. Properties such as 
the structure of a transition state (i.e. the expected positions of the constituent atoms), 
interaction energies, electronic charge distributions, dipoles and vibrational 
frequencies, reactivity or other spectroscopic quantities can be determined using 
computational methods [1]. 
The combination of quantum mechanics and molecular mechanics (QM/MM),  was first 
introduced by Warshel and Levitt in 1976 [2]. This hybrid technique combines a 
classical molecular mechanical definition of the biological system (atom positions and 
bond distances and types are defined), together with a quantum-mechanical definition 
of the region of interest (e.g. active site, substrate). The quantum-mechanical region is 
defined by approximating the atomic nuclei as point charges, and the electronic wave-
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function as a set of Gaussian approximations. In contrast to the regions defined with 
classical molecular mechanics, this allows bond breaking and bond forming to be 
modeled in reaction trajectories. Increased computational power of modern parallel and 
vector-parallel platforms has for the first time allowed simulations of realistic large 
systems, including biomolecular structures and reactions [3]. This entirely new branch of 
biological chemistry is able to complement traditional in vivo and in vitro experiments, 
offering the possibility of performing with great accuracy virtual experiments on 
computers. 
A significant amount of in silico work has been carried out on chorismate mutases, 
including E. coli chorismate mutases from E. coli (EcCM) [4-12] and Bacillus subtillis 
(BsCM) [1, 6, 9, 13-16], as well the isochorismate-pyruvate lyase from P. aeruginosa 
(PchB)[5, 17]. Indeed, The near attack conformation hypothesis (NAC), which proposes 
that the correct substrate conformation is enough to drive the reaction forward [8-12], 
was developed based on theoretical and computational work done on EcCM. 
Computational work on BsCM proposed that in addition to the NAC, electrostatic 
transition state stabilization is also required for the mutase reaction [4, 16]. In PchB, 
Marti et al. looked at the mutase and lyase activities and the effect of the A37I mutation 
on catalytic activity [17].  
The data obtained from the mutational [18], pH [19] and chemical rescue experiments 
described in chapters 2, 3, and 4 of this dissertation, identified the catalytic importance 
of the positive charge on the active site loop at position 42 (in the form of a lysine), and 
the importance of position and orientation of the positive charge with loop closure for 
efficient catalysis. Computational enzymology is the ideal tool to investigate these ideas, 
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since it enables us to observe the active site in more detail to measure angles and 
distances, as well as allowing us to test experimental conditions impossible to test in 
wet systems.  
5.2 Materials and Methods 
5.2.1 Model Building 
The initial structure used to generate the QM/MM model is the X-ray structure of PchB 
(Protein Data Bank entry 3REM) containing salicylate and pyruvate in the active site. 
For K42H mutant, the K to H mutation was performed using COOT [20]. The original 
substrates were replaced by isochorismate, overlaying the molecule over the electron 
density map to fit the ring over the salicylate density and the enolypyruvyl tail to over the 
pyruvate density using COOT [20].  The hydrogen atoms were incorporated into the 
structure and minimized using CHARMM [21]. The model was placed in a sphere of 
waters 25 Å in diameter and minimized using QM at the AM1 level (Figure 5-1). Atoms 
beyond the sphere of water were removed, and the full  system  was  relaxed  by 
successive  QM/MM  minimization  steps, equilibrated at 300 K with a time step of 1.0 fs 
during a total time of 500 ps. The  geometry  of  the  substrate  was  maintained    by  
means  of  harmonic  restraints  applied  to  internal coordinates.  
5.2.2 Single Coordinate Reactions 
Single coordinate trajectories were carried out using CHARMM using QM at AM1 level, 
in a sphere of TIP3P waters 25 Å in diameter. Coordinate was calculated as: 
= −  
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Figure 5-1: overall structure of PchB models: The PchB dimer is placed in a sphere 
of water molecules with 25 Å radius, with the isochorismate molecule at the center of 
the model. Any atoms beyond the 25 Å, are removed from the model.   
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where R and Q define bond breaking and bond forming events (Figure 5-2): 
= 	 ( )  
and  
= ( )  
where structures were calculated for values of C between -2.0 Å and 2.5 Å in 0.1 Å 
steps.  
 
Two Coordinate Trajectories 
 
Two coordinate trajectories were calculated by separating R and Q coordinates, and  
running the trajectories sequentially; first running R values from -2.0 to 2.5 Å in steps of 
0.1 while maintaining Q coordinates constant and subsequently running Q values from 
1.4 Å to 3.1 Å in steps of 0.1Å for every generated R structure. Energies were 
calculated and extracted for each structure using CHARMM and plotted as contour 
plots.  
5.3 Results and Discussion  
5.3.1 Energies of activation  
Single coordinate trajectories have been performed on wild type and K42H PchB (both 
protonated and unprotonated states of K42, reflecting conditions well above and well  
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Figure 5-2: Trajectory analysis. To the left, sample double coordinate trajectory 
model, showing wild type PchB data, with energies at each point plotted in a colored 
surface plot (highest energy red, lowest energy blue).  Double trajectories have to be 
optimized to improve the resolution of the plot. To the right, model of the transition state 
as determined by single coordinate trajectory. In red, are the H21 and O3’ atoms,  at the 
center of the bond braking and forming.  Marked with double orange arrows, the bonds 
that break to form products, and in blue, the bond generated upon product formation.   
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below the pKa of histidine). However, in order to determine energies thoughout the 
trajectories, 2 coordinate trajectories have to be carried out. This work is currently 
underway to test the proposed “energy landscape” hypothesis [19], proposed by 
Benkovic and colleagues[22, 23], and  states that rather than a two-dimentional reaction 
coordinate, catalysis occurs through a series of interconnected catalytic networks, 
influenced among other factors by protein motions and shape[22, 23]. A trajectory 
determined by 2 coordinates (as in figure 5-2, left surface plot) would determine if I 
can identify different pathways for catalysis that agree with energies calculated 
experimentally [24].   
 
5.3.2 Transition State 
 
Single trajectory experiments enabled us to determine the lengths of the bonds breaking 
and forming at the transition state (Figure 5-2, right). The breaking C2-H21 bond is the 
shortest upon formation of the transition state, at 1.2 Å, stretching until it breaks at 1.8 
Å, while the C3’-H21 bond is 1.6 Å at the transition state and shortens to 1.1 Å (in 
agreement with theoretical 1.09 Å C-H bond length [25]. The ether oxygen bond (C3-
O3’) stretches to 1.6 Å at the transition state and breaks at 1.8 Å, and the O3’ C2’ bond 
remains at 1.4 Å throughout the reaction trajectory. Interestingly, the transition state 
maintains the same overall structure in the wild type active site and the histidine 
mutants (both with the protonated and unprotonated histidines) as seen in figure 5-3, 
middle column. However, the difference in shape and size between the lysine and the  
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Figure 5-3: Active sites of tested models: wild type (a, e, i), protonated histidine 
mutant (b, f, j) and deprotonated histidine mutants (HSD in c, g, and k and HSE in d, h, 
l). showing substrate (column to the left) transition state (middle column) and product 
(column to the right).   
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histidine (the histidine is shorter) causes a 0.3 Å shift in the active site. The shift, which 
can be clearly seen in figure 5-5, a comparison between the wild type and protonated 
histidine (HSP histidine conformer, as diagramed in figure 5-4) is not caused by 
incorrect alignment of the structures, but rather it is caused by a rearrangement in order 
to accommodate the differences in shape and length of the sidechain (lysine vs. 
histidine) at position 42, while maintaining  the distance between the ether oxygen and 
the positively charged nitrogen at approximately 3 Å. This small conformational change, 
would explain the mutational effect observed between the wild type PchB and K42H in 
the pH experiments [19] at pH 5.5 where the maximal activity of PchB was observed. 
More interestingly, this shift could explain the higher mutase activity of the K42H mutant 
at its peak activity as compared to wild type [19], if this small shift is enough to better 
accommodate the mutase reaction. Further analysis of the transition state is necessary 
to identify the effect of this shift in catalysis.  
The two unprotonated histidine conformers (Figure 5-6 and 5-6) show different 
interactions with the transition state, with the most drastic being the HSD conformer, at 
a drastically different angle and 1 Å further away from the O3’ than any of the other 
conformers. Indeed preliminary single-coordinate experiments seem to indicate a higher 
energy barrier for this conformer, in agreement with previous pH and mutational 
experiments which showed the positive charge at position 42 is important for catalysis 
[18, 19].  Albeit just preliminary evidence, these trajectories indicate multiple binding 
modes in the histidine mutant, that would still lead to catalysis if the right conditions are 
met and the energy barrier is overcome by the enzyme.  
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Figure 5-4: Histidine conformers tested:  Neutral charge conformers HSE (a) and 
HSD (b) may have one of two amino groups protonated. On the positively charged 
conformer (HSP, c) BOTH amino groups are protonated.   
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Figure 5-5: Overlay of wild type PchB (dark pink) and protonated histidine mutant 
(light pink). On (a) The positively charged groups are within 0.1 A of each other, (black 
dashed line) but the overall architecture of the active site is slightly shifted in the 
histidine mutant as compared to the wild type. This is not due to an improper alignment 
of the models as can be seen in the cartoon overlay of all four models (b) where wild 
type is dark pink, protonated histidine model is pink and the two unprotonated 
conformers are colored in shades of grey.      
a. 
b. 
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Figure 5-6: Overlay of HSE unprotonated histidine conformer (gray) and 
protonated histidine mutant (light pink). Although slightly shifted, both imidazole 
groups are within 0.2 A of each other with respect to the ether oxygen, (black dashed 
line).      
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Figure 5-7: Overlay of HSD unprotonated histidine conformer (white) and 
protonated histidine mutant (light pink). The imidazole groups are positioned at 
different angles and 0.9 Å of each other with respect to the ether oxygen, (black dashed 
line).     
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5.3.3 Substrate binding and Product release 
All trajectories, both for wild type and K42H mutant, show the same binding mode for 
substrate and products, except for the HSD conformer (figure 5-3 c), where the 
enolpyruvyl tail of the isochorismate is interacting with the histidine instead of with one 
of the argininines. This results in a slightly different trajectory, with preliminary single 
coordinate experiments indicating a higher energy barrier required to overcome the less 
optimal binding mode. More detailed two-coordinate trajectories are currently underway, 
nevertheless, the data shown here is further evidence for a network of catalytic 
pathways: alternate binding modes of the substrate still lead to product formation, if the 
energy requirements are met by the enzyme through energetically favorable protein 
motions.     
 
5.4 Conclusions 
Although the computational virtual experiments are still underway, preliminary results 
are already yielding valuable information. In a more pragmatic sense, a more detailed 
structure of the transition state and its interactions with residues in the active site can be 
important for future development of inhibitors, especially in light of the fact that current 
endo-oxabicyclic  transition state analogs cannot be considered good inhibitors because 
of their low binding affinity [26, 27]. A better understanding of the charge distribution in 
the transition state could lead to a better rational design approach. In terms of 
theoretical contributions, the preliminary results agree with the previous mutational, pH, 
and chemical rescue experiments: 1.) The positive charge at position 42 is important for 
efficient catalysis; 2.) orientation and position of the positive charge at position 42 is 
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also important, as it affects position of the substrate molecule and shape of the active 
site; and 3.) Histidine mutant trajectories support the hypothesis of multiple reaction 
pathways interwoven in a network that forms a three-dimentional catalytic landscape. 
Further higher level trajectories and molecular dynamics experiments are necessary to 
understand the preliminary results in more detail. The information obtained in these 
experiments will be invaluable to develop new testable hypotheses and will provide 
shed new light on the mutational, pH, and chemical rescue experiments.  
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Chapter 6: Conclusions from PchB Experiments. 
 
6.1 How PchB derives its catalytic power is a matter of debate    
 
Two competing hypothesis propose different models as to how PchB derives its 
catalytic power. The electrostatic transition state stabilization hypothesis proposes that 
a positive charge, in the form of K42 in PchB or K39 in EcCM, stabilizes the developing 
negative charge at the ether oxygen [1-6]. A second model based on quantum 
mechanical/molecular mechanical (QM/MM) simulations [7-12], proposes that a 
substrate conformation  (near attack conformation or NAC) in which the reacting atoms 
are within van der Waals contact distance and at an orientation in which the p-orbitals 
overlap [8, 10].  The model proposes that once this conformation forms, the reaction 
occurs spontaneously, without the need for electrostatic stabilization of the transition 
state [7-10, 12].  
 
6.2 pH Experiments suggest multiple reaction pathways and  three-
dimentional free-energy landscape rather than 2-dimentional free 
energy coordinate  
 
The pH experiments described in Chapter 3 build upon mutational and thermodynamic 
analyses of PchB [13] that indicated that neither NAC formation or electrostatic 
transition state stabilization completely account for catalysis [13].   
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The pH experiments allowed me to test the contribution of both electrostatic transition 
state stabilization and near attack conformations, for both lyase and mutase activities  in 
a single mutant enzyme. The results indicate that rather than one or the other catalytic 
mechanism, both contribute to lowering of the energy barrier to drive catalysis, resulting 
not in a 2 dimensional free energy trajectory but rather a free energy landscape 
resulting from a network of different possible pathways, similar to those proposed by 
Benkovic [14-17].  
 
6.3 Chemical Rescue experiments suggest active site loop has to be 
organized for effective lyase catalysis  
 
The mutagenesis and pH dependence [18] experiments provided evidence that the 
positive charge at position 42 is important for efficient lyase catalysis, but some other 
mechanism (possibly the formation of a NAC) was sufficient for lyase catalysis. This 
suggested a network of catalytic mechanisms contributing to catalysis. Thermodynamic 
data [19], suggested that loop motions are also important for catalysis.  The next 
question to ask was whether enzyme movements also contribute to catalysis, as has 
been proposed by Benkovic [27], and if so, how. Prior to the chemical rescue 
experiments described in Chapter 4, we hypothesized that the closing of the active site 
loop was important for catalysis, in particular because the K42, required for efficient 
catalysis, is in said loop.  The ability to rescue catalytic activity of the K42C variant 
through the generation of a γ-thio-lysine at position 42, but not through the generation of 
the hydroxyl derivative, gives further support to the importance of electrostatic transition 
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state stabilization in the isochorismate-pyruvate lyase reaction. The ineffectiveness of 
the propylamine as a non-covalent chemical rescue reagent indicates that the positive 
charge must be organized with the loop for efficient catalysis: correct loop organization 
leads to efficient lyase catalysis. This once again points to a catalytic network with 
multiple contributors to catalysis: substrate shape in the active site, electrostatic 
stabilization of the transistion state, and loop organization all contribute to catalysis. 
 
6.4 Computational enzymology experiments agree with and shed new 
light on previous experimental results  
 
QM/MM experiments are still ongoing. However, some valuable information has been 
extracted from these first sets of experiments. Preliminary results agree with the 
previous mutational, pH, and chemical rescue experiments, indicating that the positive 
charge at position 42 is important for efficient lyase catalysis and the orientation and 
position of the positive charge is very important. Snapshots of the active site throughout 
the reaction trajectory suggest that the position of the positive charge affects position of 
the substrate molecule and shape of the active site when substrate binds. This accounts 
for the mutational effect seen in the pH experiments between wild type PchB and K42H 
at maximal K42H activity – the shape and orientation of the positive charge is not 
optimal for catalysis. Unexpectedly, histidine mutant trajectories support the hypothesis 
of multiple reaction pathways interwoven in a network that forms a three-dimentional 
catalytic landscape: protonated and unprotonated mutant active sites show different 
modes of binding substrate and transition state, yet these modes may all lead to 
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turnover, given the right conditions. Further higher level trajectories and molecular 
dynamics experiments are necessary to understand these preliminary results in more 
detail. These experiments are also yielding more detailed structure of the transition 
state and its interactions in the active site. This information may lead to future rational 
design of transition state analog inhibitors. Further higher level  QM/MM computational 
experiments are needed to understand the lyase chemistry in more detail, but 
preliminary results have already yielded valuable information.  
Taken together, these three different lines of experimentation all point to the conclusion 
that a positive charge at the 42 position must be organized within the active site for 
efficient catalysis. 
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Chapter 7: PvdA introduction 
7.1 Classification of Flavoprotein Monooxygenases 
Flavoprotein monooxygenases are enzymes that use flavins an electron rich organic 
cofactor, to transfer molecular oxygen to organic compounds[1]. As shown on Table 7-1  
flavoprotein monooxygenases  have been categorized into 6 classes ([2] A-F, Table 1).  
Class A and Class B enzymes are single component monooxygenases (encoded by a 
single gene), that use FAD as redox center, bound in a Rossmann-like, dinucleotide-
binding domain [3]. Class A enzymes use either NADH or NADPH, which is released 
immediately upon FAD reduction,  while Class B flavoproteins use exclusively NADPH 
as electron donor, which remains bound in the active site throughout the oxidative half 
reaction[3]. Classes C-F of flavoprotein monooxygenase on the other hand encompass 
two component enzymes (a flavin reductase and an oxidase), that use either FMN 
(Class C), or FAD (D-F), and interchangeably use NADH or NADPH as electron 
donor[3].  As opposed to the Rossman-like domains of the class A’s and B’s, class C 
monooxygenases are characterized by a TIM-barrel fold[3]. There are no structures 
available for Class D or E monooxygenases but are believed to contain Rossmann-like 
folds, and class F enzymes are mostly alpha helical[3].    
7.2 PvdA is a Class B Flavoprotein 
PvdA, the ornithine monooxygenase from Pseudomonas aeruginosa is the subject of 
the second half of this dissertation. PvdA catalyzes an FAD dependent hydroxylation of 
ornithine to hydroxyornithine using molecular oxygen and NADPH as electron donor [4].   
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Table 7-1: Classification of Flavoprotein Monooxygenases1 
Class Subclass Reaction Representative  Genes Coenzyme Cofactor 
       
A - hydroxylation epoxidation 
para-Hydroxy-benzoate 
hydroxylase 1 FAD NAD(P)H 
       
       
B Flavin 
Dependent 
heteroatom 
hydroxylation yeast FMO 
1 FAD NADPH 
   
Baeyer Villiger ketone to ester Hyclohexanone monooxygenase 
   
N-Hydroxylating primary amine hydroxylation PvdA 
       
       
C 
- 
light emission 
S-oxidation 
ketone to ester 
Luciferase 2- reductase and oxidase FMN NAD(P)H 
       
       
D 
- hydroxylation 
para-Hydroxy-
phenylacetate 
hydroxylase 
2- reductase 
and oxidase FAD NAD(P)H 
       
       
E - epoxidation Styrene monooxygenase 
2- reductase 
and oxidase FAD NAD(P)H 
       
       
F - halogenation Tryptophan 7-halogenase 
2- reductase 
and oxidase FAD NAD(P)H 
       
 1 Table adapted from van Berkel et al. 2006 [3]  
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PvdA is a member of the class B family of flavin dependent monooxygenases 
(FDMOs)[5, 6].  As mentioned above, class B monooxygenases share a common set of 
characteristics, albeit catalyzing a wide variety of reactions: 1.) They are single 
component enzymes encoded by a single gene, 2.) They have Rossmann-like 
dinucleotide binding domains to bind flavin and electron donor, 3.) They use FAD as the 
redox center, which is stably bound to the enzyme, 4.) They use NADPH exclusively as 
the electron donor (never NADH and finally, 5.) the NADP+ remains bound in the active 
site throughout the oxidative half reaction [3].  
7.3 Class B Flavoprotein Monooxygenases 
The class B family of monooxygenases is subdivided into 3 subclasses: flavin 
containing monooxygenases (FMOs), microbial N-hydroxylating monooxygenases, and 
Baeyer Villager monooxygenases (BVMOs) [3].  
 
7.3.1 Flavin Containing Monooxygenases  
Flavin Containing Monooxygenases (FMOs), were originally named “mixed-function 
oxidases” because of their ability to hydroxylate a wide variety of xenobiotics in liver 
microsomes [7]. FMOs are found in all mammals, including humans, other eukaryotic 
organisms, including plants and yeast, and some bacteria [8-11]. Mammalian FMOs 
play a similar role to that of cytochrome P450 system in detoxification of drugs and 
other xenobiotics[12-18]. Mammalian FMOs catalyze the monooxygenation of carbon-
bound reactive heteroatoms nitrogen, sulfur, phosphorus, selenium, and iodine (Figure 
7-1 b) [19]. In plants, FMOs have been found to be involved in the tryptophan- 
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Figure 7-1: Comparison of Catalytic cycles of the Class B Flavoprotein 
monooxygenases. PvdA (a) catalytic cycle is unique from FMOs (b) in regards to the 
timing of the binding of the substrate and the formation of a relatively stable 
peroxyflavin. Baeyer-Villiger Monooxygenases’ catalytic cycle (c) is characterized by the 
formation of the Criegee adduct necessary for the insertion of the oxygen atom. Unlike 
most N-hydroxylating monooxygenases’ cycle (d) and FMOs, PvdA stabilizes the 
peroxyflavin intermediate long enough to be observable through pre-steady state kinetic 
experiments [5]. Figure adapted from [20]  
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dependent biosynthesis of plant development hormone auxin, catalyzing N-
hydroxylation of tryptamine [21]. In contrast to mammalian and plant FMOs, yeast FMO 
does not hydroxylate nitrogen-containing compounds; it is only active with biological 
thiol [10], and is required for proper disulphide bond formation in some proteins by 
generating an oxidizing environment in the endoplasmatic reticulum  [22]. Bacterial 
FMOs (bFMOs) are relatively rare as only a few representatives have be identified [23]. 
Of the known bFMOs, the FMO from Methylophaga aminosulfidivorans is the best 
characterized [9]. It is known that it is able to oxidize a number of amines, and indole is 
readily oxidized by the enzyme to produce indigo by recombinant E. coli cells 
expressing the bacterial FMO, but physiological substrates are yet to be identified [24].  
7.3.2 Baeyer-Villiger Monooxygenases 
Class B Baeyer-Villiger Monooxygenases (Type I BVMOs) are FAD, NADPH dependent 
monooxygenases with the ability to catalyze the incorporation of one atom of molecular 
oxygen into a substrate while reducing the second atom to water[25-28]. Baeyer-Villiger 
monooxygenases catalyze a variety of monooxygenation reactions[26] including 
synthesis of iridoids and steroids in plants, aflatoxin synthesis in fungi [29] and 
metabolism of aliphatic methyl ketones, tarpenes, alicyclic hydrocarbons and aromatic 
compounds in bacteria [26, 30-32]. The two best studied BVMOs are phenylacetone 
monooxygenase (PAMO) from Thermobifida fusca [33] and cyclohexanone 
monooxygenase (CHMO) from Acinobacter spp [34-36]. PAMO catalyzes the 
monoxygenation of phenylacetone to benzyl acetate, while CHMO catalyzes the 
insertion of an oxygen in the cyclohexanone ring to form ε-caprolactone (Figure 7-1 
c)[25, 31, 37, 38].    
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7.3.3 N-Hydroxylating Monooxygenases 
PvdA belongs to the N-hydroxylating subclass of class B FDMOs [6, 39, 40]. However, it 
shares functional characteristics of both class A and class B enzymes, and was 
hypothesized to share structural characteristics of both as well (Figure 7-2) As the 
name implies, this subclass catalyzes the hydroxylation of primary amines (Figure 7-1 a 
and d). The best studied of the N-hydroxylating flavoprotein monooxygenase proteins 
are the ornithine hydroxylases from Pseudomonas aeruginosa (PvdA) and that from 
Aspergillus fumigatus (SidA) and the lysine hydroxylase from Escherichia coli (IucD) 
[41]. Unlike the other two subclasses, class B enzymes have only begun to be studied 
biochemically in detail recently. The structure of PvdA presented in Chapter 8 is the first 
structure of an enzyme in this subclass.   
7.4 Mechanism of Catalysis of Flavoproteins.  
At the core of the catalytic mechanism of all flavin dependent monooxygenases lies the 
redox chemistry of the flavin adenine dinucleotide (FAD), and its ability to cycle through 
reactive redox states and permit nucleophillic attacks that lead to active oxygen species 
necessary for monooxygenation.   
7.4.1 General Flavin Chemistry 
 
Flavins are a group of redox cofactors produced from vitamin B2 (riboflavin) and 
characterized by a catalytically important isoalloxazine hetero-tricyclic ring structure with 
a central diene, diimine moiety conjugated to electron withdrawing carbonyl groups[42]. 
The  Flavin Adenine Dinucleotide (FAD) molecule required for PvdA catalysis consists  
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Figure 7-2: Comparison of the closest PvdA hypothesized homologs with known 
structures. Prior to the solution of the structure of PvdA, it had been proposed that it 
would share features of both Class A and Class B enzymes, albeit the low sequence 
identity. The FAD binding domains have been colored in different tones of blue. 
NAD(P)H binding domains in tones of red and pink and substrate binding domains in 
purple on the Class A structures, and wheat color on CHMO. Note that the FMO does 
not have a substrate binding domain, and PHHY has an additional domain, in green, of 
unknown function. 
  
132 
 
of a riboflavin moiety containing the catalytically relevant isoalloxazine ring, bound to the 
phosphate group of an adenine diphosphate molecule (Figure 7-3). The electronic 
configuration of the isoalloxazine ring permits the FAD to readily accept or donate 
electrons and convert between two different redox states [43]. In its fully oxidized 
quinone form, the flavin is an aromatic ring system, whereas the fully reduced form 
(hydroquinone) is not aromatic, and in a higher energy conformation [44]. The flavin can 
be fully reduced by accepting two hydrogen atoms (a net gain of two electrons) 
becoming a hydroquinone, or partially reduced (semiquinone) by accepting one electron 
and one proton from the quinone redox state, or by donating an electron and a proton 
from the fully reduced hydroquinone state[44]. In its reduced form, the flavin ring can 
undergo nucleophillic attacks at either the N5 or the C4a [44]. In the case of flavoprotein 
monooxygenases, the reduced flavin undergoes a nucleophillic attack by molecular 
oxygen, resulting in the reactive oxygen species necessary for catalysis.  
7.4.2 Overview of the Flavin Redox Cycle (Figure 7-4) 
 
In order for the flavin to react with molecular oxygen, it has to be in its reduced (quinone 
or semiquinone) form. Most commonly the electron transfer happens either between 
other redox centers such as hemes or iron-sulfur centers and the flavin, or reducing 
molecules such as NAD(P)H. The reduced (electron rich) flavin is able to transfer an 
electron to molecular oxygen, generating a complex between the newly formed 
superoxide and the flavin radical [23, 24]. A spin inversion results in formation of 
reduced oxygen, generating a reactive C(4a)-hydroperoxyflavin species adduct between 
the C(4a) of the flavin and molecular oxygen[45]. The peroxyflavin is unstable, decaying  
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Figure 7-3: Structure of  Flavin Adenine Dinucleotide. The Isoalloxazine ring in the 
yellow rectangle, is the catalytic functional group of the FAD. The diene-diimine moiety, 
in red, is able to accept one or two electrons (semiquinone and hydroquinone states) 
and react with oxygen molecules to form reactive oxygen species.    
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Figure 7-4: General Flavin Redox Cycle. A reducing molecule (most commonly 
NAD(P)H, reduces the flavin (a), changing the electronic structure of the diene diimine 
group of isoalloxazine ring (in blue). This allows reactivity with molecular oxygen (b) to 
form a very reactive peroxyflavin. Some enzymes, including Baeyer-Villiger 
monooxygenases, stabilize the peroxyflavin, allowing nucleophilic oxygenation of the 
substrate (d). Other enzymes stabilize the hydroperoxyflavin intermediate, which reacts 
with the substrate via electrophilic oxygenation (e). Both mechanisms, nucleophilic or 
electrophilic oxygenations generate an unstable hydroxyflavin (f) that degrades back to 
the oxidized isoalloxazine ring and a water molecule. If no substrate is present to accept 
the oxygen, uncoupling occurs, forming toxic hydrogen peroxides as the isoalloxazine 
ring re-oxidizes. Figure adapted from van Berkel et al. 2006 [6]        
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to form hydrogen peroxide and an oxidized flavin. However, the flavoprotein is able to 
stabilize the hydroperoxyflavin long enough to oxygenate the substrate. Depending on 
the protonation state of the flavin intermediate (peroxy COO-, or hydroperoxy (COOH), 
either a nucleophilic or electrophilic attack on the substrate is performed and a single 
atom of molecular oxygen is incorporated into the substrate, while the other oxygen 
atom is reduced to water [46]. 
7.4.3 PvdA catalytic cycle (Figure 7-5) 
The C4a-peroxy and hydroperoxyflavin intermediates are highly unstable intermediates 
which, uncoupled from substrate oxidation generate highly toxic peroxides with the 
regeneration of the oxidized flavin [47]. In order to prevent uncoupling, flavoprotein 
monooxygenases use a variety of methods to stabilize and protect these reactive 
intermediates[44]. In the case of Class A flavoprotein monooxygenases, such as para-
hydroxybenzoate hydroxylase (PHBH) and phenol hydroxylase (PHHY), reduction of the 
flavin by NAD(P)H is coupled to binding of the substrate: NAD(P)H oxidation (and flavin 
reduction) rates are significantly accelerated by the binding of the substrate to the active 
site[44].  In  Class  B  FMOs,  BVMOs,  and  some  NMOs,  the  reduction  of  the  flavin  is  
independent of substrate binding, but the reactive oxygen intermediate is stabilized 
awaiting substrate binding[44]. For FMOs, the hydroperoxyflavin intermediate is 
stabilized, as there is no detectable peroxyflavin intermediate [48]. In BVMOs however, 
the peroxyflavin is stabilized, and coexist in equilibrium the hydroperoxyflavin [49, 50]. 
Based on pre-steady state kinetic analyses, unlike primary sequence homologs SidA 
and IucD (Figure 7-6) that behave more like FMOs, there is evidence that PvdA forms a 
stable peroxyflavin intermediate awaiting ornithine binding[4, 5] (Figure 7-5 b). Once 
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the ornithine binds, it has been hypothesized that the N5-amino group of the ornithine 
donates a proton to the peroxyflavin to generate the hydroperoxyflavin and the reactive 
ornithine ready to be hydroxylated[4, 5] (Figure 7-5 c). Chapter 8 includes the work 
solving the structure of PvdA.  
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Figure 7-5 PvdA Catalytic cycle. (A) The reductive half reaction in PvdA involves the 
reduction of the flavin (FAD) by a molecule of NADPH. (B) Molecular oxygen reacts with 
the reduced FAD forming a peroxyflavin, as ornithine binds to the active site, donating a 
hydrogen to the peroxyflavin reactive oxygen species, forming a hydroperoxyflavin while 
activating the N5amino group of the ornithine. (C) The activated amino group of the 
ornithine attacks the hydroperoxyflavin, generating the product, hydroxyornithine, and 
hydroxyflavin (D). The hydroxyflavin oxidizes, releasing a water molecule and the 
products, the hydroxyornithine and NADP+. This mechanism was first proposed by 
Meneely et al. (2009) [5] Figure adapted from Olucha and Lamb 2011 [51] 
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Figure 7-6: Sequence alignment  between N-hydroxylating monooxygenases. 
Ornithine hydroxylases of Pseudomonas aeruginosa (PvdA)  and  of  Aspergilus 
fumigatus (SidA), as well as lysine hydroxylase from Escherichia coli (IucD) are the 
most widely studied NMOs. PvdA shares 40% identity and 73% similarity with SidA and 
25% identity and 59% similarity with IucD. The structure of PvdA described in chapter 6 
is the first structure of an N-hydroxylating monooxygenase. Prior to the PvdA structure, 
the hydrophobic-residue rich putative FAD binding motif (a, in yellow) commonly found 
in FAD dependent monooxygenases [52] was hypothesized to be conserved in all three 
homologs. The putative NADPH binding motif (b, in red) was also hypothesized to be 
conserved among NMOs, including arginine 239 in PvdA, proposed to confer NADPH 
vs NADH selectivity in this class of enzymes[52]. Prior to structure of PvdA, the 
ornithine binding motif was proposed to be a “FATGY” motif (c, blue) conserved among 
the three homologs[52]. This motif will be discussed in chapter 6.       
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Chapter 8: Structures of Pseudomonas aeruginosa PvdA 
 
The work discussed in this chapter has been published as a research article: 
 
Olucha J, Meneely KM, Chilton AS, Lamb AL, Two structures of an N-hydroxylating 
flavoprotein monooxygenase: ornithine hydroxylase from Pseudomonas aeruginosa. 
Journal of Biological Chemistry, 2011. 286(36): p. 31789-98. 
 
and an invited review: 
 
Olucha, J. and A.L. Lamb, Mechanistic and structural studies of the N-hydroxylating 
flavoprotein monooxygenases. Bioorg Chem, 2011. 39(5-6): p. 171-7. 
 
8.1 Introduction 
For successful infection, gram negative bacteria have evolved mechanisms to acquire 
nutrients essential for survival in low nutrient environments [1, 2]. One of these 
mechanisms is the production and secretion of siderophores, small molecules with high 
affinity for iron that allow the bacteria to sequester ferric iron from infected tissues [3, 4]. 
Siderophores are not only important for iron acquisition; these small molecules have 
also been shown to play an important role in quorum sensing [5, 6]. In Pseudomonas 
and Yersinia species it has been shown that siderophores are essential components for 
virulence [5-7].  For these reasons siderophore biosynthetic pathways are being 
considered as potential drug targets. 
As outlined in the previous chapter, Pseudomonas aeruginosa produces two 
siderophores, pyochelin and pyoverdin via two distinct biosynthetic pathways. Pyoverdin 
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is a large peptide-based siderophore with two iron chelating N5-formyl-hydroxy-ornithine 
hydroxamate moieties at the core of the molecule (see Chapter 6 figure 5). The 
ornithine hydroxamates are synthesized via a two-step process; PvdA hydroxylates the 
side chain amine of the L-ornithine, and a transformylase, PvdF, formylates the 
hydroxyornithine. The formyl-hydroxyornithine is incorporated onto the siderophore by 
non-ribosomal peptide synthases [5, 8, 9]. 
PvdA belongs to the class B family of flavoprotein monooxygenases and therefore 
should meet the following criteria [10]: 1.) it uses FAD as a redox cofactor, 2.) NADPH 
but not NADH serves as electron donor, 3.) NADP+ remains bound in the active site 
until all products are released, 4.) it is encoded by a single gene and 5.) based on 
sequence homology, PvdA has well defined α/β-nuclotide binding FAD and NAPH 
binding domains [11, 12]. PvdA meets most of these requirements with some 
qualifications: albeit using FAD exclusively as flavin redox center (as opposed to FMN), 
PvdA does not bind FAD stably in solution, prior to the work described in this chapter 
there was no structural information and it was uncertain whether NADP+ remained 
bound through the oxidative half reaction[13-17].  
As described in the previous chapter, Class B flavoproteins are divided into three 
distinct subclasses: 1.) flavin containing monooxygenases (FMOs) that hydroxylate 
heteroatoms through a hydroperoxyflavin intermediate, 2.) Baeyer-Villiger 
monooxygenases (BVMOs), which catalyze monooxygenation via a peroxyflavin 
intermediate and a Crieggee adduct[15, 18-20]; and 3.) N-hydoxylating 
monooxygenases (NMOs), the subclass PvdA belongs to.    
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The most studied of the NMOs are PvdA (ornithine hydroxylase from Pseudomonas 
aeruginosa) [21-23], SidA (the ornithine hydroxylase from Aspergillus fumigatus) [11] 
and the lysine hydroxylase from Escherichia coli (IucD) [24]. Although all three enzymes 
have been characterized biochemically in detail, the structure of PvdA described in this 
chapter is the first structure of an NMO enzyme and the first structure of a class B 
enzyme with redox center (FAD), electron donor (NADP+) and product 
(hydroxyornithine) bound in the active site together. Overall sequence identity between 
the three enzymes is 15% and similarity is 46%. The two ornithine hydroxylases (SidA 
and PvdA)  share  40% sequence identity  and 73% sequence similarity, whereas IucD 
and PvdA share 25% sequence identity and 59% similarity [12, 25]. Detailed 
biochemical work on each of these three enzymes reveals differences between the 
catalytic mechanisms of PvdA and the other two NMOs. PvdA carries out catalysis via a 
unique FAD redox cycle, unlike that of either SidA or IucD. Unlike SidA, IucD and flavin 
containing monooxygenases (FMOs), a peroxyflavin intermediate is observed during the 
catalytic cycle (like Baeyer-Villiger monooxygenases), and like Class A 
monooxygenases, the peroxyflavin intermediate forms most efficiently in the presence 
of substrate. Unlike Baeyer-Villiger monooxygenases, however, the reactive 
intermediate is the hydroperoxyflavin intermediate, not the peroxyflavin [14, 17, 22, 26]. 
Like other members of this family however, the electron donating NADPH remains 
bound (as NADP+) until the product is released [14, 17, 21-23]. Moreover, in spite of the 
conserved sequence identity, out of the three enzymes, only SidA is able to bind FAD 
tightly; neither IucD or PvdA bind the cofactor stably in solution [11, 12, 24].    
148 
 
In this chapter I present the crystallographic structures with the oxidized and reduced 
forms of the flavin, at different points of the FAD redox cycle, and show structural 
evidence that PvdA is structurally a member of the N-hydroxylating monooxygenase 
subclass and of the Class B FDMOs. Finally, we show small active site changes in the 
oxidized and reduced forms of PvdA that represent different modes of binding of 
substrate/products during catalysis.     
8.2 Materials and methods 
8.2.1 Over-expression and Purification  
Native PvdA. PvdA was cloned, over-expressed and purified as previously described 
[22]. 
Seleno-methionine PvdA (SeMet PvdA). The method for over-expression of PvdA 
SeMet was adapted from Van Duyne et al. 1992 [27] with several modifications. M9 
Minimal media was inoculated with 10 mL of overnight culture per liter of media. The 
methionine biosynthesis pathway was inhibited by adding a solution containing 100 mg 
each of L-lysine, L-phenylalanine, and L-threonine, 50 mg each of of L-isoleucine, L-
leucine, and L-valine, and 60 mg of DL-selenomethionine per liter of culture. Protein 
purification was induced 15 minutes after the addition of the amino acid solution with the 
addition of IPTG to a final concentration of 400 µM. SeMet PvdA was purified using the 
same protocol as native PvdA with the addition of 1 mM βME to all buffers.   
8.2.2 Crystallization 
Native PvdA. The best crystals of native PvdA were obtained through the hanging drop 
vapor diffusion method in  9.5% PEG 8000, 25% glycerol, 60 mM phosphate monobasic 
149 
 
(pH 5.0) some of which can be seen on figure 8-1, a, b, and c. PvdA did not form 
crystals without FAD, NADPH and L-Ornithine, so the protein solution was prepared by 
adding FAD and substrates to a 16 mg/ml (as measured by Bradford) solution of PvdA 
to a final molar ratio of 1:3:20:150 (protein:FAD:NADPH:L-Ornithine). The protein 
solution was allowed to incubate on ice for 30 minutes prior to setting up the 
experiments. After the incubation period, 3 µl drops with a 1:1 ratio of protein solution to 
mother liquor solution were prepared over 600 µl of mother liquor solution. Rod shaped 
yellow crystals grew to a size of ~200 µm x 50 µm x 50 µm in 3 days at 18 °C. 
8.2.3 SeMet PvdA.  
Crystals of SeMet PvdA were obtained in similar conditions to native PvdA (8% PEG 
8000, 15% glycerol, 80 mM MES, pH 5.5). As with native PvdA, SeMet PvdA did not 
form crystals without FAD, NADPH and L-Ornithine, so protein solution was prepared 
with FAD and substrates with the same ratios as native PvdA. The best SeMet crystals 
grew to a size of ~150 µm x 40 µm x 40 µm in 5 days at 18 °C at a protein concentration 
of 9 mg/ml (measured by Bradford) in 2 µl drops. In order to keep a reduced 
environment, 10µl of 1M β-mercapto ethanol (βME) was added to each well prior to 
drop setup) 
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Figure 8-1: Different PvdA crystal morphologies. Different concentrations of the 
precipitant (PEG 8000) led to a range of rod-shaped crystals (a, b, c). Modification of 
the pH led to different morphologies (rod-shaped in a,b and c versus pizza boxes in d, 
e, and f). Rod-shaped crystals were used to solve the structure of PvdA. Pizza box 
shaped crystals did not result in usable data. 
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8.2.4 Native PvdA – reduced. 
 A flake of sodium hydrosulfite (sodium dithionite) was added to a native PvdA 
experiment (Figure 8-2). The flake was allowed to dissolve and the drop and crystals 
were monitored for discoloration from yellow to clear for 30 minutes. Crystals were 
harvested after the 30 minute incubation period, cryo-protected and flash cooled.  
8.2.5 Cryoprotectants. 
 Native PvdA crystals were harvested and transferred to a mother liquor drop with 11% 
PEG 8000, 60 mM KPi monobasic, and 20% glycerol. In order to prevent crystals from 
cracking because of diffusion of FAD and substrates/products out of the crystal, these 
were added to the drop to a final concentration of 21 mM FAD, 41 mM NADPH and 166 
mM L-ornithine. Harvested SeMet PvdA crystals were transferred to a cryo-protectant 
with the same composition as the native PvdA cryo-protectant, with the addition of 2mM 
βME. Reduced PvdA crystals were harvested and transferred to a cryo-protectant with 
the same composition as native PvdA cryo-protectant, with a flake of sodium dithionite 
allowed to dissolve in it to maintain a reducing environment. All crystals were flash 
cooled to 77 K in liquid nitrogen. 
8.2.6 Data Collection, processing and structure determination 
8.2.6.1 SeMet PvdA. 
 Multiple anomalous dispersion experimental data for SeMet PvdA crystal were 
collected on beamline 9-2 at the Stanford Synchrotron Radiation Lightsource (SSRL).  
Peak (0.979112 Å), Inflection (0.979304 Å) and remote (0.918402 Å) wavelengths were  
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Figure 8-2: Reduction of  PvdA crystals. 30 minutes after the addition of sodium 
dithinite to a drop of PvdA cryoprotectant containing a PvdA crystal, drop and crystal 
lost the yellow flavin color, characteristic of oxidized flavin, indicating the flavin is 
reduced.   
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determined by a selenium fluorescence scan (K-edge 12.6578 keV).  Data were 
collected for 120° of the crystal in 0.5° oscillations and exposure time of 5 seconds. 
Detector distance was set to 360.5 mm. Data were indexed and scaled to 2.8 Å 
resolution using X-ray Detector Software (XDS) [28]. (Table 8-1). AutoSolve and 
AutoBuild, from the Python-based Hierarchical Environment for Integrated 
Crystallography (PHENIX) software suite [29] were used to determine the location of 12 
Se atoms (FoM = 0.42, overall score= 63), initial phase estimates, and to build the initial 
model.  The initial model was built with 750 residues. Further model building refinement 
of the structure was accomplished using Coot [30] and Refmac5 from the CCP4 
software suite [31] (Table 8-1).  
8.2.6.2 Native PvdA. 
 Data for native PvdA were collected on beamline 9-2 at the SSRL for 180° in 0.5° 
oscillations with 10 second exposures at 1 Å wavelength and a detector distance of 200 
mm (Figure 8-3).  
Data were scaled and indexed to 1.95 Å resolution using XDS. SeMet and native 
crystals were isomorphous so the initial SeMet model and phase estimate was used to 
build the higher resolution native PvdA model using Refmac5 from the CCP4 software 
suite [31].  Further model building refinement of the structure was accomplished using 
Coot [30] and Refmac5 from the CCP4 software suite (Table 8-1).  
8.2.6.3 Reduced Native PvdA.  
Data for native PvdA were collected on beamline 9-2 at the SSRL for 120° in 0.25° 
oscillations with 5 second exposures at 0.97946 Å wavelength and a detector distance  
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Table 8-1: Data Collection and Refinement Statistics 
Data Collection1      
 Selenomethionine Native 
 Peak Inflection Remote Oxidized Reduced 
Wavelength (Å) 0.9791 0.9793 0.9184 1.000 0.9795 
Space Group I4122 I4122 I4122 
Unit Cell (Å) a = b = 130.94, c = 316.50 a = b = 130.94, c = 318.52 a=b=128.16, c=316.51 
Resolution range (Å) 36.6 - 2.7 36.8 - 1.9 39.26-3.03 
Completeness (%) 99.7 (98.4) 99.7 (97.6) 99.7 (98.4) 99.5 (97.5) 99.4 (96.0) 
Total reflections 275715 275906 275985 741798 246515 
Unique reflections 37946 37964 37949 108180 26002 
I/s 17.1 (4.4) 17.1 (4.5) 19.0 (4.6) 15.3 (4.1) 25.1 (5.8) 
Rsym2 (%) 9.1 (42.1) 9.1 (42.8) 8.8 (42.9) 6.7 (41.2) 8.0 (40.7) 
Multiplicity 7.3 (7.3) 7.3 (7.3) 7.3 (7.3) 6.9 (6.5) 9.5 (9.2) 
      
Number of refined 
selenium sites 
12   
Anomalous correlation 
between half sets 
0.36 0.33 0.16   
Mean Figure of Merit 4 0.42 0.97 0.91 
Mid slope of anomalous 
probability 
1.2 1.2 1.1   
      Refinement      
Resolution range (Å)    36.74-1.90 39.26-3.03 
Number of reflections    102726 23360 
Rfactor6    19.2 21.5 
Rfree    21.7 27.1 
Number of protein, nonhydrogen atoms  6561 6541 
Number of ligand and solvent atoms  584 220 
Ramachandran Allowed (%)   100 100 
R.m.s. bond length (Å)    0.0154 0.0162 
R.m.s. bond angles (°)    1.56 1.89 
Average B (Å2)       
     Protein    32.0 59.0 
     Ligands    27.4 68.0 
     Water    33.5 n/a 
      
1All data were collected that the Stanford Synchrotron Radiation Laboratory, beamline 9-2.  Values in parentheses are for the highest resolution shells: 2.84 - 2.7 Å for 
selenomethionine data, 2.0 - 1.9 Å for oxidized data, and 3.19-3.03 Å for reduced data.  
2Rsym =∑| I - < I >| / ∑I, where I is the observed intensity and áIñ is the statistically weighted absolute intensity of multiple measurements of symmetry related reflections.  
3Anomalous correlation between half sets = ∑||FPH ± FP| -FH(calc) |/∑|FPH| reported for all centric reflections.  
4Mean figure of merit = ˂α∑P(a)eia/∑P(α)>, where a is the phase and P(α) is the phase probability distribution. 
5Phasing power = <|FH|>/<||FP + FH|-|FPH||> reported for all reflections.  
6R = ∑|Fo - k|Fc||/∑|Fo|, R from the working set and Rfree from the test set. 10% percent of the refelctions were reserved for the calculation of the Rfree. 
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Figure 8-3: Diffraction images of datasets collected and used to determine the 
structure of PvdA.   
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of 408 mm. Data were scaled and indexed to 3.1 Å using XDS. Structure determination 
was performed via molecular replacement using Phaser from the CCP4 software suite 
with chain B of the native structure with waters, FAD and substrates omitted as model. 
Further model building refinement of the structure was accomplished using Coot and 
Refmac5 from the CCP4 software suite [31] (Table 8-1).  
8.2.7 Crystallographic models 
The final native PvdA model contains two chains per asymmetric unit (Figure 8-4). 
Chain A is missing residues 1-9, 199-205, 360 and 428-443, while chain B is missing 
residues 1-9, 200-206, and 420 – 443. Missing residues are located in flexible loops and 
had poor electron density due to low occupancy. Both chains have FAD, NADP+ and 
hydroxy-ornithine in the active site. The NADP+ nicotinamide moiety and ribose in chain 
A active site are not modeled due to poor electron density, as is the nicotinamide moiety 
in chain B.  The model includes 376 waters and 4 phosphate molecules. Ramachandran 
analysis as calculated by PROCHECK [32] shows good geometry and angles, with 
90.8% of residues in allowed regions and 9.2% of residues in additionally allowed 
regions.  
The reduced native PvdA model contains two chains per asymmetric unit, but with 
different lattice contacts. Both chains A and B have poor or no electron density for 
residues 1-8, 200-207, and 428-443. In addition chain B is missing residues 359 and 
360. Both chains contain FAD, hydroxy-ornithine, and NADP+ in the active site. In 
contrast to the non-reduced native model, the NADP+ nicotinamide moiety in both 
active sites had density and therefore was able to be modeled.   
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a. b. 
 
Figure 8-4: Shape of the unit cell and assymetric unit. Rod shaped crystals had a 
large unit cell (a) with a centered-tetragonal spacegroup (I4122) and two PvdA 
molecules in the assymetric unit (b) forming a dimer with twofold crystallographic 
symmetry.  
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8.2.8 Structural alignments 
Root mean square deviations were calculated using LSQMAN [33] of the DEJAVU 
program suite. 
 
8.3 Results 
8.3.1 Molecular Replacement 
The first attempts at structure determination were performed using molecular 
replacement using Phaser from the CCP4i suite [31], and PHENIX [29]. There were no 
structures for the closest homologs to PvdA (SidA and IucD), therefore molecular 
replacement models were generated from hypothesized functional homologs with 
known structures: class A enzymes  phenol hydroxylase (PHHY) from Trichosporum 
cutaneum (PDB 1FOH), para-hydroxybenzoate hydroxylase from Pseudomonas 
fluorescens (PDB 1PBD), and Class B enzymes bacterial flavin containing 
monooxygenase from Methylophaga aminisulphidivorans (PDB 2VQ7) and 
cyclohexanone monooxygenase from genus Acinetobacter (PDB 3GWD). These 
enzymes’ structures were used as complete models and as chimeric combinations of 
domains. Log Likelihood Gains never surpassed 100 points (acceptable) but the Rsym  
never dropped below 0.5 (indicating random placement of the model versus the density 
map). 
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8.3.2 Twinning 
Initial improper processing of native datasets using a space group with lower symmetry 
(I4 vs I422) indicated twinning of the data (two or more lattices overlapping at an angle). 
After further investigation it was determined that there was indeed no twinning, but 
rather the programs used for processing (HLK and Mosfilm) were not processing the 
data correctly unless specifically given the correct spacegroup.     
8.3.3 Surface entropy reduction 
Protein crystallization is dependent on whether it can reproducibly form intermolecular 
contacts that can sustain a three dimensional lattice. In some instances crystallization is 
prevented by an "entropic shield" composed of clusters of residues with high intrinsic 
conformational entropy [34]. Crystallization is very sensitive to entropy changes 
involving both the solvent and the protein. Incorporation of protein molecules into the 
lattice carries a negative entropy term, and a thermodynamic cost [34]. The surface 
entropy reduction approach involves the replacement of surface exposed, high entropy 
amino acids with residues that have small, low entropy side chains such as alanines. 
Using the SerP server [34], a high entropy cluster (Q120/E121/Q122) was located and 
confirmed to be on the surface via homology modeling using PHHY as model. Attempts 
to purify the entropy reduction mutant PvdA Q120A/E121A/Q122A were never 
successful as the protein readily precipitated out of solution.  
8.3.4 Heavy atom soaking 
As an alternative to molecular replacement, I began the process of soaking crystals in 
heavy atoms, to obtain data for multiwavelength anomalous dispersion or multiple 
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isomorphous replacement (Table 8-2). Dissolving the heavy metal compounds and 
adding the solution to the crystal drops resulted in dissolution of the crystals due to high 
sensitivity to small changes in the ionic strength of the solution. Adding small flakes of 
the undissolved heavy metal compound to the drops overcame this obstacle, but I could 
not measure the amount of heavy metal compound added to the solution correctly. I 
was only able to incorporate tungsten and mercury successfully into the crystal lattice, 
but never in enough quantity to be useful in MAD.  Other metals that incorporated 
successfully destroyed the architecture of the lattice, which was not evident until data 
was collected at the synchrotron.  
  
8.3.5 Phasing and Overall Structure 
An initial phase estimate was determined by multiwavelength anomalous dispersion 
using a selenomethionine (SeMet) substituted form of PvdA. Crystallographic statistics 
can be seen in Table 8-2. The initial SeMet model was used to phase an isomorphous 
1.9 Å native dataset. The assymetric unit contains two PvdA monomers related by a 
non-crystallographic two-fold axis and a 950 Å2 interface (PROTORP[35]). This dimer is 
a crystallographic artifact; dynamic light scattering and size exclusion chromatography 
experiments indicate that PvdA is a monomer in solution [21, 22] . Each monomer is 
composed of three well defined domains (Figure 8-5). The FAD binding domain, is 
composed of 250 residues, separarated in three different segments from both N and C-
termini. The NADPH binding domain, is composed of 144 residues in two segments.  
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Table 8-2: Heavy metal derivatization 
Conditions Cryoprotectant Derivative Heavy 
Atom 
    
PEG 8K 20% Glycerol KCl6Ir Ir 
PEG 8K 20% Glycerol KCl6Os Os 
Pentaerythrol 20% Ethylene 
Glycol 
ThCl3 Th 
PEG 8K 20% Glycerol LaNO3 La 
PEG 8K 20% Glycerol PCMB Hg 
Pentaerythrol 20% Ethylene 
Glycol 
KAuCl4 Au 
Pentaerythrol 20% Ethylene 
Glycol 
KBr4Pt Pt 
Pentaerythrol 20% Ethylene 
Glycol 
CdCl2 Cd 
Pentaerythrol 20% Ethylene 
Glycol 
HgI2 Hg/I 
Pentaerythrol 20% Ethylene 
Glycol 
AuCl3 Au 
Pentaerythrol 20% Ethylene 
Glycol 
KReCl6 Re 
Pentaerythrol 20% Ethylene 
Glycol 
PrCl3 Pr 
Pentaerythrol 20% Ethylene 
Glycol 
HgO Hg 
Pentaerythrol 20% Ethylene 
Glycol 
DyCl3 Dy 
Pentaerythrol 20% Ethylene 
Glycol 
EuCl3 Eu 
Pentaerythrol 20% Ethylene 
Glycol 
Sm(NO3)3 Sm 
Pentaerythrol 20% Ethylene 
Glycol 
LuCl3 Lu 
Pentaerythrol 20% Ethylene 
Glycol 
YbCl3 Yb 
Pentaerythrol 20% Ethylene 
Glycol 
IC3 I 
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Figure 8-5: Stereo cartoon overlay of PvdA oxidized (darker colors) and reduced 
(lighter colors). In blue the FAD binding domain, red the NADPH binding domain, and 
yellow the ornithine binding domain. There are no large structural differences between 
oxidized and reduced structures.    
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Both FAD and NADPH binding domains are folded in a α/β nucleotide binding fold. The 
ornithine binding domain is the smallest of the three domains, composed of 45 residues 
in two segments; three helices inserted in a loop of the NADPH binding domain 
(residues 248-285) and a single helix inserted in the C-terminus segment of the FAD 
binding domain (residues 398-404). This can best be observed in the topology diagram 
(Figure 8-6, b), and sequence alignment between SidA, IucD, and PvdA (Figure 8-7) 
8.3.6 FAD binding domain 
The overall architecture of the FAD binding domain is a prototypical  α/β-dinucleotide 
binding fold characteristic of the glutathione reductase family of flavoproteins [36]. In 
PvdA, a central five-stranded parallel β-sheet  flanked to one side by five helices and to 
the other by a three strand antiparallel β-sheet with an N-terminal β-α-β dinucleotide 
binding consensus sequence. The standard GXGXXG consensus sequence is usually 
found in a loop between a beta stand and an alpha helix, and allows a charge-dipole 
interaction between the alpha helix and the phosphate groups of the dinucleotide 
molecule [10, 37-39]. As shown in figure 8-8 In PvdA, the GXGXXG consensus 
sequence is substituted by a GXGXXN sequence (residues 17-22, with the sidechain of 
the Asn-22 hydrogen- bonding to the backbone of Gly-17 and Gln-395). The FAD binds 
to a cleft in an extended conformation, with the isoalloxazine ring directed towards the 
active site, but unlike most other characterized flavoprotein monooxygenases from the 
same class, the cleft is shallow and most of the flavin molecule is solvent exposed, 
possibly explaining why PvdA does not bind FAD stably [22, 26].  
 
164 
 
a. b. c. 
 
Figure 8-6: Topology diagrams of Class B enzymes.  In shades blue, the FAD 
binding domain, red/pink the NADPH binding domains, and yellow/wheat the substrate 
binding domains. CHMO (a), PvdA (b), and bacterial FMO (c) all have two dinucleotide 
binding domains with similar topologies. However, the substrate binding domains are 
significantly different. FMO does not have a substrate binding domain, CHMO substrate 
binding domain is a 5 helix insert in the NADPH binding domain, and PvdA’s ornithine 
binding domain is composed of a 3 helix insertion in a loop from the NADPH binding 
domain, and a single helix insertion from the FAD binding domain.    
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Figure 8-7: Sequence alignment of SidA, PvdA and IucD.  Secondary structure over 
alignment based on PvdA structure (blue is FAD binding, Red is NADPH binding, and 
yellow is ornithine binding). Highlighted in blue are  residues involved in FAD binding. 
The blue rectangle indicates the βαβ motif. Highlighted in red are the residues involved 
in NADPH binding. The green rectangle indicates a consensus sequence previously 
hypothesized to be involved in substrate binding[11]. This sequence in actually part of 
the NADPH binding cleft in PvdA. In yellow, the five residues that form a hydrogen 
bonding and salt bridge network that stabilizes the ornithine substrate.  
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Figure 8-8: Stereo view of the FAD binding region of PvdA. The FAD binding motif 
in PvdA is the characteristic β-α-β with a glycine rich 6 residue loop that permits a 
dipole/charge interaction between the phosphate groups of the FAD and the alpha-helix. 
In PvdA one of the glycines is replaced by an asparagine (GXGXXN consensus 
sequence vs GXGXXG) that hydrogen bonds with glutamine 395.  Figure adapted from 
Olucha and Lamb, 2009 [12]  
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8.3.7 NADPH binding domain 
The NADPH binding domain is analogous (albeit smaller) to the FAD binding domain in 
overall structure. PvdA conserves the α/β architecture of nucleotide binding domains, 
with a central five-stranded parallel β-sheet flanked to one side by a three stranded 
antiparallel β-sheet and on the other by three helices. At the core of the domain, is the 
β-α-β motif with the glycine rich consensus sequence (residues 214-218) that allows the 
previously mentioned dipole-charge interaction between an α-helix and the phosphates 
of the NADPH. Two residues, Arg-240 and Ser-286 form hydrogen bonding interactions 
with the phosphate of the adenine ribose, and confer the specificity of PvdA for NADPH 
vs NADH [22, 26] (Figure 8-9). The nicotinamide moiety of the NADP+ product bound to 
the active site is not modeled due to the lack of density. This lack of density suggests 
some flexibility of the NADPH molecule in the active site required for catalysis.  
8.3.8 Ornithine binding domain.  
The ornithine binding domain is composed of 4 helices coming from loop insertions in 
the FAD and NADPH binding domains. In the model, hydroxyornithine lies in the cleft 
formed at the interface between the FAD and ornithine binding domains. Five residues, 
Gln-64 and Lys-69 from the FAD binding domain, and Asn-254, Thr-283 and Asn 284 
from the ornithine binding domain, form a salt bridge and hydrogen bond network with 
two waters and the ornithine. The network stabilizes the ornithine in place poised for 
hydroxylation, 5.5 Å away from the C4a, a distance enough to fit a dioxygen molecule 
(~3 Å long). Asn 254 and the backbone of Thr-283 form hydrogen bonds, and Lys-69 
forms a salt bridge with the backbone of the ornithine, conferring the stereoselectivity of  
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Figure 8-9: Stereo cartoon of the NADPH binding motif. Also an β-α-β motif with a 
glycine rich loop. NADPH vs NADH specificity is conferred by arginine 240 and serine 
286, which hydrogen bond with the phosphate group of the 2’ position of the adenine 
ribose.   
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PvdA for L-ornithine (vs D-ornithine). Gln-64 and Asn-284 form a hydrogen bond 
network with the sidechain of the ornithine, positioning the substrate in the right 
orientiation in the active site for hydroxylation. The electron density for the active site 
can be seen in figure 8-10 and a stereo view of the active site of the oxidized structure 
can be seen in figure 8-11  
 
8.3.9 Reduced Structure 
A structural alignment of oxidized and reduced structures of PvdA using LSQMAN 
(r.m.s.d. of 0.4 A for all Cα) reveals no large overall structural differences between the 
two structures (Figure 8-5). The most significant differences can be observed in the 
active site itself. The reduced structure was determined to 3.03 Å, therefore no 
structured waters were observable. The most notable difference however is the density 
for NADP+/NADPH. There is no density for the nicotinamide moiety of the NADP+ in the 
oxidized structure. On the other hand, the NADPH in the reduced structure has well 
defined density for the nicotinamide moiety, in spite of the significantly lower resolution.   
The density for the hydroxyornithine is very well defined in the oxidized structure, which 
is not the case in the reduced structure, and the molecule had to be modeled as 
ornithine for lack of density for the hydroxyl group. Finally, Gln-64 and Asn-284 are 
slightly rotated in the reduced structure as compared to the oxidized structure. This 
rotation is enough for the Gln-64 to no longer hydrogen bond with the side chain of the 
ornithine, but the Asn-284 is still able to form a hydrogen bond with the side chain 
amine (Figure 8-12).  
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Figure 8-10: Electron density map overlayed on the model of the oxidized 
structure’s active site (to σ=1.5). There is well defined density for the 
hydroxyornithine (including the hydroxyl group), but there is no density for the 
nicotinamide moiety of the NADP+  
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Figure 8-11: Stereo cartoon of the active site of PvdA (oxidized). Five residues 
(Q64, K69, N254, T283 and N284) form a hydrogen-bond and salt bridge network with 
two waters and the substrate/product. This network confers the PvdA active site high 
specificity and stereoselectivity.  
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Figure 8-12: Stereo cartoon of the active site of PvdA (reduced). Ornithine, not 
hydroxyornithine, was modeled into the active site. The nicotinamide moiety of the 
NADPH had well defined density and was modeled as well. At 3.03 Å resolution, no 
waters could be modeled into the structure.   
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8.3.10 Comparison With Homologs  
A structural comparison between PvdA and other Class B flavoprotein with known 
structures indicates that PvdA is structurally distinct from other members of the family 
for which structures are available. A side-by-side comparison of the topologies of the 
individual domains of  bacterial FMO, cyclohexanone monooxygenase (BVMO) and 
PvdA reveals that although all three enzymes maintain Rossmann-like folds (βαβ motif 
with  β-sheets flanked by helices), the secondary structure is distinct in all three 
proteins.  
 Structural alignment with bacterial FMO using least-squares alignment using LSQMAN 
indicates  an r.m.s.d. of 1.8 Å over 213 aligned backbone carbons (of the possible 414 
modeled in the PvdA structure). Comparison of the FAD binding domains indicates 
indicates higher homology (r.m.s.d.  of 1.6 Å over 163 Cα). Comparison of the NADPH 
binding domains shows 2.0 Å for 58 Cα atoms. Bacterial FMO does not have a 
substrate binding domain.  
A structural alignment between cyclohexanone monooxygenase (closed structure) from 
genus Acinetobacter indicates slightly better structural homology, with an r.m.s.d. of 1.8 
Å over 263 aligned Cα (versus 213 of FMO). An alignment of the FAD binding domains 
reveals a 1.7 Å r.m.s.d. over 157 Cα and and alignment of the NADPH binding domain 
reveals an r.m.s.d. of 2.0 Å for 93 atoms. The substrate binding domains are both 
alpha-helical in nature with an r.m.s.d. of 2.2 Å over 13 Cα.  
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8.4 Discussion 
The two structures presented in this chapter are the first determined structures of a 
member of the N-hydroxylating flavoprotein monooxygenases. In addition, it is the first 
Class B structure with the flavin, NADP+ and substrate/product bound simultaneously in 
the active site. As such, these structures provide insight into the structure-function 
relationship in these enzymes [12, 23].  
The overall architecture is mostly the same in all three subclasses. Both FAD and 
NADPH binding domains have Rossmann-like folds, characteristic of dinucleotide 
binding domains [14, 40, 41]. The topology for these domains is somewhat different for 
each of the enzymes, partially due to the arrangement of the domains and the insertion 
of the substrate binding domain (which is not present in bFMO [42-44]). In CHMO the 
substrate binding domain is a five helix insert in the NADPH binding domain, whereas in 
PvdA the substrate binding domain is smaller (four helices) and divided into two 
insertions: three helices in an FAD binding domain loop and one in the NADPH binding 
domain.  It has been suggested that there are large conformational changes throughout 
the catalytic cycle in CHMO [45, 46]. The overall structural similarities between the 
oxidized and reduced structures (at different points in the catalytic cycle) would indicate 
that this is not the case for PvdA, but it cannot be discounted without further structures 
at different points in the catalytic cycle.  
One of the biggest differences between PvdA and other class B flavoprotein 
monooxygenases is the binding of FAD. Most other known class B flavoproteins bind 
the FAD cofactor very tightly, to the point where many enzymes are unable to 
175 
 
incorporate exogenous FAD in vitro unless the enzyme is partially unfolded and re-
folded [10, 38, 39, 44, 47-52].  This makes sense from an evolutionary standpoint 
because FAD is energetically expensive to make, and is the redox center without which 
the enzyme is inactive. This is notoriously not the case for PvdA. PvdA does not purify 
with FAD bound, and assays have to be performed with excess exogenous FAD in the 
reaction buffer [22, 26].   
The two structures of PvdA also provide structural evidence for the high substrate 
selectivity of PvdA. The orientations of the residues in the active site provide a hydrogen 
bonding network that not only prevents hydroxylation of amines on shorter or longer 
side chains, but also promotes preferential binding to the correct stereoisomer (L vs D).  
Biochemical evidence suggests that L-lysine (one methylene group longer than 
ornithine) binding promotes NADPH oxidation, but no hydroxylysine is produced [26]: 
the side chain amine of the substrate has to be at a precise distance from the C4a and 
in the correct orientation to undergo hydroxylation.  
PvdA shows high selectivity for NADPH versus NADH as electron donor. This had 
previously been determined biochemically and it is in accordance with other class B 
flavoprotein monooxygenases [22, 26]. Now we have structural evidence for this 
preference: Arg-240 and Ser 286 bind to the phosphate group that is different between 
the two molecules, thus providing tighter binding for NADPH. Furthermore, NADPH 
seems to enter the active site from a tunnel different from ornithine or FAD.  Another 
noteworthy observation is the lack of electron density for the nicotinamide moiety in the 
oxidized structure. The lack of density most likely indicates high mobility of the NADP+ in 
the active site once the flavin has been reduced. The flexibility of the NADP+ would 
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enable it to move “out of the way” to make room for the oxygen, since it remains in the 
active site throughout the oxidative half reaction. The conformational flexibility of the 
NADP+ might also play a role in blocking solvent accessibility into the active site, 
thereby protecting the flavin-oxygen intermediates from non-productive uncoupling. 
PvdA shows a higher uncoupling rate (NADPH oxidation and peroxide formation without 
product hydroxylation) than reported in other flavoprotein monooxygenases [22, 26]. 
This might be at least partly due to the high solvent accessibility of the active site. The 
C4a has to be protected from solvent in order to accept the oxygen molecule [14, 53, 
54]. It has been previously shown that NADP+ remains bound in the active site of some 
enzymes to stabilize the highly reactive hydroperoxyflavin intermediate, but the 
mechanism is a matter of debate. Furthermore, crystals only grow in the presence of 
high concentrations of ornithine, which may suggest a conformational change upon 
substrate binding for crystals to form. It would be possible that FAD binding encourages 
a conformational change that promotes NADPH binding. Ornithine binding blocks 
solvent accessibility while promoting reduction of the flavin (Figure 8-13, a), and 
induces a conformational change in the active site that encourages the NADP+   
molecule to move away from the reactive center, and further blocking solvent from 
entering the active site, protecting the C4a to prevent uncoupling (Figure 8-13, b). This 
model needs to be further investigated biochemically and structurally, through single 
turnover experiments looking at the flavin redox cycle in more detail and though 
selective mutations in the active site of PvdA.  
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a. 
b. 
 
Figure 8-13: Stereo surface depiction showing ornithine solvent exposed surface 
(green, a) and FAD solvent exposed surface in orange and NADPH in red (b). 
Ornithine, FAD, and NADOH would seem to be protecting the isoalloxazine ring from 
solvent, blocking the tunnels of an otherwise very solvent exposed active site.     
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Chapter 9: Conclusions to the PvdA Research 
 
9.1 The structures of PvdA are the first structures of an N-
hydroxylating flavoprotein monooxygenase (NMOs)  
  
Flavoproteins are ubiquitous in nature and a lot of scientific effort has been directed 
towards understanding these enzymes functionally and structurally [1-5]. Several of the 
closest functional homologs of PvdA like class A flavoprotein monooxygenases phenol-
hydroxylase (PDB 1FOH) and para-hydroxybenzoate hydroxylase (PDB 1PBD) or  
class B flavoprotein monooxygenases cyclohexanone monooxygenase  (PDB 3GWD) 
and flavin-dependent monooxygenase (PDB 2VQ7) have multiple published structures. 
However, none of the NMOs ( including the most studied  PvdA [6, 7], SidA [8] and IucD 
[9] ) had published structures, resulting in a significant amount of conjecture over 
structural characteristics of these enzymes based on sequence alignments and 
homology models using other class A and class B enzymes as models [1, 10-16].  
Moreover, the structures of PvdA are the first of the class B enzymes containing all 
three components (flavin, electron donor and substrate/product) and in two different 
positions in the catalytic cycle: the reduced structure at the beginning of the cycle (after 
substrate binding) and the oxidized structure at the end of the cycle (after product 
release). New information can be extracted from the structures that sheds new light on 
biochemical observations and leads the way to the formation of new hypotheses.  
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9.2 A network of hydrogen bonds and salt bridges stabilizes the 
substrate in the right orientation and confers stereospecificity  
 
Contrary to the previously proposed hypothesis that a ‘F-A-T-G-Y’ motif (L-A-T-G-Y 
sequence in PvdA, residues 351-355) was involved in substrate binding [17], in PvdA,  
this sequence is actually part of the NADPH binding pocket [18]. The ornithine in PvdA 
is stabilized by five non-consecutive residues: Q64, K69, N254, T283 and N284: Q64 
and N284 orient the N5-amino-group of the ornithine for hydroxylation, and K69, N254, 
and T283 stabilize the ornithine backbone. The network of interactions stabilizes the 
ornithine in such a way that only the correct stereoisomer with a sidechain of the correct 
length will bind stably and  position the amino group at the right distance from the C4a 
position of the flavin for hydroxylation. This explains the previously observed substrate 
specificity of PvdA[15, 16]. Furthermore, the majority of these residues are conserved in 
both SidA and IucD [11], so I hypothesize that ornithine and lysine bind in a similar 
manner in SidA and IucD, respectively.  
 
9.3 The FAD binding domain was previously hypothesized to be part 
of a membrane binding region 
 
Prior to the completion of the PvdA structure, it had been hypothesized that the N-
terminal region of PvdA also constituted a membrane binding region overlapping with 
the FAD binding motif [19-21]. The structure of PvdA, however, shows that this is not 
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the case: the putative membrane binding region is part of the β-a-β dinucleotide binding 
motif [18] and cannot serve as  a membrane binding region.  
 
9.4 The shallow FAD binding cleft explains the inability of PvdA to 
bind FAD tightly 
 
Most flavoproteins bind the flavin tightly[10, 13, 14, 22-28], including the ornithine 
hydroxylase SidA. PvdA and IucD on the other hand bind FAD weakly; where two to 
four fold more FAD than PvdA has to be added to a solution for assays and 
crystallization[15, 16, 29]. Comparing the solvent accessible surface structure of PvdA 
to the published structures flavoprotein monooxygenases  shows that while in other 
flavoprotein monooxygenases the flavin is completely buried and solvent inaccessible 
[30-34], in PvdA the FAD binding cleft is shallower, leaving most of the FAD solvent 
exposed. It will be interesting to compare structures of IucD, and PvdA (neither of which 
bind the flavin tightly) to SidA, which does bind it tightly. Based on the sequence 
alignment in Chapter 7, Figure 7-8, I hypothesize that IucD, 46 amino acids shorter 
than PvdA, will also have a solvent exposed FAD. I also hypothesize that SidA has a 
buried cleft protecting the FAD.   
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9.5 PvdA’s solvent exposed active site might account for the high rate 
of uncoupling observed in biochemical experiments  
 
Biochemical characterization of PvdA indicates a high degree of uncoupling (NADPH 
oxidation resulting in production of peroxides instead of substrate hydroxylation)[15, 16], 
as compared to other flavoprotein monooxygenases. Both oxidized and reduced 
structures of PvdA show a solvent exposed active site. Only when NADP+ and 
substrate/product are bound in the right conformation in the active site are the reactive 
flavin/oxygen intermediates protected from the solvent. This at least partially explains 
why the NADP+ remains in the active site throughout the oxidative half reaction (after 
flavin has been reduced): it protects the reactive oxygen species from solvent.  
 
9.6 Oxidized and reduced structures suggest NADPH/+ is flexible in 
the active site 
One observation that caught my attention was the lack of electron density for the 
nicotinamide moiety of the NADP+ in the oxidized structure as compared to the reduced 
structure where the nicotinamide ring electron density is well defined. This lack of 
density is suggestive of a highly flexible NADP+ (able to sample multiple conformations) 
in the active site once the flavin has been reduced.  The flexibility of the NADP+ could 
serve a dual purpose: 1.) would enable it to move out of the way to make room for 
oxygen binding (since the NADP+ remains in the active site throughout the oxidative half 
reaction) and  2.) the conformational flexibility of the NADP+ might also play a role in 
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blocking solvent accessibility into the active site, by allowing it to adopt conformations in 
which it is able to protect the flavin-reactive oxygen intermediates from solvent.   
 
9.7 Conclusion 
 
Determination of the PvdA structure has allowed us to place the biochemical data in a 
structure-function relationship context. However, further crystallographic work to identify 
structural determinants of flavin-intermediate stabilization is in progress. A new structure 
of reduced PvdA with norleucine in the active site is in progress in an attempt to capture 
a reactive peroxyflavin intermediate. In light of the structures mutational analyses can 
be performed on the active site residues to study the hydrogen bonding network, and 
determine what hydrogen bonds are important for catalysis. Finally, flavoproteins are 
believed to be poor candidates for drug design because of their ubiquity: Flavin and 
NAD(P)H analogs would inhibit both bacterial and human enzymes. However,   the 
crystal structures of PvdA enable for the first time a detailed view of the active site and 
the binding mode of ornithine/hydroxyornithine.  This new data opens a door to rational 
drug design: incorporating groups to an ornithine backbone that would increase binding 
affinity to the active site, or electron withdrawing/donating groups that would 
promote/destabilize hydroxyornithine formation.  
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Appendix: PvdF 
PvdF catalyzes the transformylation of hydroxyornithine to generate the N5-formyl, N5-
hydroxy-ornithine  that is incorporated as the ferric iron binding moiety in the pyoverdin 
siderophore. PvdF has only been shown to be active in whole cell extract assays, using 
iodine oxidation reactions[1]. Biochemical characterization of the enzyme in vitro 
requires: 1.) synthesizing cofactor (10-formyl-tetrahydrofolate), 2.) synthesizing 
substrate (not commercially available) and 3.) developing an assay.  
 
A.1 Synthesis of 10-formyl-tetrahydrofolate 
Sequence aligments indicate PvdF is a member of the glycinamide ribonucleotide 
transformylase (GART) family of transformylases [1]. This family of transformylases use 
10-formyl-tetrahydrofolate as the cofactor for nucleophillic transformylation of the 
substrate [2]. 10-formyl-tetrahydrofolate is unstable in solution and is not commercially 
available. This tetrahydrofolate cofactor either has to be synthesized or biochemical 
assays have to be coupled with a tetrahydrofolate formylase. However, the only 
available assay to determine product formation was already coupled to PvdA, to 
produce substrate, hydroxyornithine, which also not commercially available.  
As shown in figure A-1, 10-formyl-tetrahydrofolate can be generated from 5-formyl-
tetrahydrofolate in a two-step process, according to the Himes/Rabinowitz synthesis 
scheme [3-5]. 5-formyl-tetrahydrofolate is dissolved in 1M ME at 2°C on ice, in order to  
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Figure A-1: Himes/Rabinowitz scheme for conversion of 5-formyl-tetrahydrofolate 
to 10-formyl tetrahydrofolate. 5-formyl-tetrahydrofolate (a) can be precipitated out of 
solution as 5,10 methenyl tetrahydrofolate (b) with the slow acidification of the solution 
on ice. The 5,10 methenyl compound can be stored stably at -20°C indefinitely. 
Generating 10-formyl-tetrahydrofolate (c) from the 5,10 methenyl tetrahydrofolate 
requires dissolving the 5,10 methenyl tetrahydrofolate in a solution buffered at pH above 
7.     
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maintain a reducing environment and prevent the quick degradation of the compound at 
room temperature. 5-formyl-tetrahydrofolate is converted to 5,10-methenyl-
tetrahydrofolate by lowering the pH of the solution with HCl, until a yellow precipitate 
begins to form (5,10-methenyl-tetrahydrofolate has a lower solubility in water at low pH). 
After a four hour incubation on ice, the precipitate is ultracentrifuged and supernatant 
discarded. Dry 5,10-methenyl-tetrahydrofolate is stable for long periods of time at -20°C. 
In order to convert the 5,10-methenyl-tetrahydrofolate into 10-formyl-tetrahydrofolate, 
the 5,10-methenyl-tetrahydrofolate can be resuspended in solution buffered at pH 7 or 
above (Figure A-1) [6, 7]. Due to the instability of the 10-formyl-tetrahydrofolate it has to 
be made fresh from a 5,10-methenyl-tetrahydrofolate stock for every experiment. As 
seen on figure A-2 I could obtain all three molecules, and interconversion between the 
three molecules can be observed spectometrically.    
A.2 Synthesis of hydroxy-ornithine.  
In an attempt to uncouple future PvdF assays from PvdA to produce hydroxyornithine, I 
attempted to synthesize hydroxyl-ornithine with the help of Dr. Tom Prisinzano and his 
graduate student Dr. Kim Lovell. The synthesis protocol was based on that published by 
the Miler miller group (1999) from protected CBZ-ornithine as shown on figure A-3[8].   
As shown on figure 3, a five step scheme would result in CBZ-hydroxyornithine as the 
final product with approximately 80% yield. The CBZ protective group could later be 
removed via hydrogenation[8]. Unfortunately, degradation of the product of step 2, 
resulted in small or no yields to continue with step 3. There are several factors that 
might have affected the degradation of the oxaziridine compound, the most likely of 
which is the purity of the  meta-chloroperoxybenzoic acid (mCPBA). mCPBA is a strong 
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oxidant, only available for purchase at 70% purity or less, due to its propensity for 
violent reactions at higher purities [8]. For that reason, all of my synthesis experiments 
were performed with at lower purity levels than the authors of the scheme were using 
(they recrystallized the mCPBA to obtain higher purity). Synthesis of hydroxyornithine is 
still being attempted by the Prisinzano lab with mixed results. 
A.3 High-Performance Liquid Chromatograph (HPLC) assay for PvdA 
and PvdF.  
PvdA activity can be measured monitoring NADPH oxidation, but in order to observe 
hydroxylation of ornithine a cumbersome iodine oxidation colorimetric assay is the only 
available tool [1]. Assays for the measurement of PvdF transformylation are even more 
cumbersome, involving an iodine oxidation step similar to the PvdA assay, with an 
additional step where strong acid is added to the solution and then autoclaved [1, 9, 10].  
The cumbersomeness of the assay resulted in inaccuracies that could be avoided with a 
simpler assay. Ornithine, hydroxyornithine, and formyl-hydroxyornithine have, in theory, 
different hydrophobic properties. This led to the hypothesis that we would be able to see 
small differences in HPLC traces using a C-14 reverse phase column (Figure A-4). 
However, neither ornithine, or the products hydroxyornithine or formylhydroxyornithine 
absorb strongly enough to be detected in a spectrophotometer. To overcome this, I 
derivatized the compounds after each reaction with FMOC-Cl under basic conditions, a 
technique most commonly used in N-terminal sequencing, and allows observation of 
aminoacids at 263 nm wavelengths, and due to the reactivity of the FMOC-Cl, results in 
100% derivatization [11-14].   
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A.4 Conclusion 
My contributions to this project are allowing other members of the lab to continue 
making progress in the biochemical and structural characterization of PvdF.  
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Figure A-2: Absorbance spectra of 5-formyl-tetrahydrofolate, 5,10-methenyl 
tetrahydrofolate, and 10-formyl-tetrahydrofolate. The three absorbance spectra (5-
formyl-tetrahydrofolate in red, 10-formyl-tetrahydrofolate in green, and 5,10-methenyl 
tetrahydrofolate in yellow) were obtained from a single sample, showing we could 
generated 10-formyl-tetrahydrofolate from 5-formyl-tetrahydrofolate, and store it stably 
as 5,10methenyl-tetrahydrofolate. The spectra for all three molecules agree with those 
published in the literature [15].   
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Figure A-3: Scheme for synthesis of hydroxyornithine as described by Lin and 
Miller (1999)[8]. CBZ protected ornithine (a) can be converted to hydroxyornithine (d) 
via two intermediate steps, generating first an oxaziridine (b) and nitrone (c). 
Unfortunately the generation of (b) proved difficult due to the instability of the 
compound, resulting in the inability to proceed with the synthesis further. Figure adapted 
form Lin et al. 1999    
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Figure A-4: HPLC traces of Ornithine and Hydroxyornithine. Ornithine (red dashed 
trace) and hydroxyornithine (blue trace) have enough differential hydrophobicity that 
they can be separated via a C-14 reverse phase column in a methanol gradient. The 
molecules could be visualized at 263 nm via a derivatization step with FMOC-Cl.  The 
hydroxyornithine was generated enzymatically with PvdA.   
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